SNAPSHOT

Created at: 2017-02-09 13:27

AOP ID and Title:


AOP 54: Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children
Short Title: NIS inhibition and DNT effects

Authors


Alexandra Rolaki, Francesca Pistollato, Sharon Munn and Anna Bal-Price* (*corresponding author)

European Commission Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra, Italy


Status

Author status OECD status OECD project SAAOP status
Open for comment. Do not cite EAGMST Under Review 1.28 Included in OECD work plan

Abstract


The thyroid hormones (TH) are essential for brain development, maturation, and function as they regulate the early key developmental processes such as neurogenesis, cell migration, proliferation, myelination and neuronal and glial differentiation. Normal brain development and cognitive function in mammals relays on sufficient production of TH during the perinatal period. The function of Na+/I- symporter (NIS) is critical for the physiological production of TH levels in the serum, as it is a membrane bound glycoprotein that mediates the transport of iodide form the bloodstream into the thyroid cells, and this constitutes the initial step for TH synthesis. NIS is a well-studied target of chemicals, and its inhibition results in decreased hormone synthesis and secretion into blood leading to subsequent TH insufficiency in the brain with detrimental effects in neurocognitive function in children. The present AOP describes developmental neurotoxicity (DNT) effects induced by the decreased levels of TH in the blood and consequently in the brain, as a result of NIS inhibition. Many environmental chemicals have been reported to disrupt iodide uptake, but the studies that have been focused on NIS inhibition are mainly restricted to perchlorate and some small ionic or drug-like molecules. Perchlorate, which is the most potent inhibitor of NIS, has been associated with reduced TH production and also with cognitive deficits in animals and humans.



Summary of the AOP


Stressors


Name Evidence
Perchlorate Strong
Nitrate Strong
Thiocyanate Strong
Dysidenin Strong
Aryltrifluoroborates Moderate

Molecular Initiating Event

Title Short name
Inhibition, Na+/I- symporter (NIS) Inhibition, Na+/I- symporter (NIS)

424: Inhibition, Na+/I- symporter (NIS)

Short Name: Inhibition, Na+/I- symporter (NIS)

Stressors

Name
Perchlorate
Nitrate
Thiocyanate
Dysidenin
Aryltrifluoroborates
Econazole
5-(N,N-hexamethylene) amiloride (HMA)
Small molecules: ITB3, ITB4, ITB5, ITB9

Evidence for Perturbation of this Molecular Initiating Event by Stressor

Thyroid Disrupting Chemicals (TDCs) are defined as the xenobiotics that interfere with the thyroid axis with different outcomes for the organism. A very well-studied mechanism of action of the TDCs is the reduction of the circulating levels of THs by inhibiting hormone synthesis in the thyroid gland. For example, perchlorate is a very potent inhibitor of iodide uptake through the sodium/iodide symporter (Tonacchera et al., 2004). The mechanism of perchlorate action is quite simple, as it is believed to be mediated only by the NIS inhibition (Dohan et al., 2007; Wolff, 1998). Additionally, thiocyanate and nitrate are two known inhibitors that have been found to reduce circulating TH levels (Blount et al., 2006; Steinhaus et al., 2007), but they are both less potent than perchlorate (Tonacchera et al., 2004). However, there are also contradictory results from other studies that showed no correlation between thyroid parameters and perchlorate levels in humans (Pearce et al., 2010; Amitai et al., 2007; Tellez et al., 2005). Finally, ten more small simple-structured molecules were identified in a large screening study (Lecat-Guillet et al., 2008b) that could block iodide uptake by specifically disrupting NIS in a dose-dependent manner. These molecules were named Iodide Transport Blockers (ITBs). There are few organic molecules that lead to NIS inhibition but no direct interaction with NIS has been determined (Gerard et al., 1994; Kaminsky et al., 1991). Up to date, only dysidenin, a toxin isolated from the marine sponge Dysidea herbacea, has been reported to specifically inhibit NIS (Van Sande et al., 2003). Finally, the aryltrifluoroborates were found to inhibit iodide uptake with an IC50 value of 0.4 μM on rat-derived thyroid cells (Lecat-Guillet et al., 2008a). The biological activity is rationalized by the presence of the BF3− ion as a minimal binding motif for substrate recognition at the iodide binding site.



Biological Organization

Level of Biological Organization
Molecular

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
mouse Mus musculus Strong NCBI
Pig Pig Strong NCBI
Life Stage Applicability
Life Stage Evidence
Pregnancy Moderate
Birth to <1 month Moderate
Sex Applicability
Sex Evidence
Mixed Strong

Apart from the human, functional NIS protein has been also identified in 3 other species, namely the rat (Dai et al., 1996), the mouse (Perron et al., 2001) and the pig (Selmi-Ruby et al., 2003). Mouse and rat contain 618 amino acid residues, while the human and pig contain 643. There are several NIS variants that produce three active proteins in the pig due to alternative splicing at mRNA sites that are not present on the other species (Selmi-Ruby et al., 2003).

NIS orthologs are discussed in the review by Darrouzet's group ( Darrouzet et al., 2014). Interestingly, functional differences have been identified between mouse or rat NIS (mNIS or rNIS, respectively) and human NIS (hNIS). The rat and themouse orthologs were shown to accumulate radioisotopes more efficiently than the human protein (Dayem et al., 2008; Heltemes et al., 2003). The molecular basis of these functional differences could be helpful for further characterization of NIS. Zhang and collaborators showed that rNIS is localized in a higher proportion at the plasma membrane than hNIS and the N-terminal region up to putative TM7 appears to be involved in this difference (Zhang et al., 2005). These authors also reported differences in the kinetics of the Na+ binding, implicating the region spanning from TM4 to TM6 and Ser200 of hNIS. They, thus, proposed that this region could be involved in sodium binding (Zhang et al., 2005). In our laboratory, it was shown that the Vmax of the mouse protein is four times higher than the Vmax of the human protein when expressed in the same cell line (HEK-293) (Dayem et al., 2008; Darrouzet et al., 2014). The KmI value determined for hNIS (9.0 ± 0.8 μM) was significantly lower than the KmI for the mouse protein (26.4 ± 3.5 μM) whereas the KmNa values were not significantly different. Similarly to the rat protein, mNIS is predominantly localized in the plasma membrane whereas the human ortholog is detected intracellularly in 40% of the cells in which it is expressed (Darrouzet et al., 2014). However, the difference in the Vmax values does not only seem to be related to the higher intracellular localization of hNIS. Using chimeric proteins between human and mouse NIS, we showed that the N-terminal region up to TM8 is most probably involved in iodide binding, and that the region from TM5 to the C terminus could play an important role in targeting the protein to the plasma membrane (Dayem et al., 2008). One of the long-term goals of these studies is the engineering of a chimeric NIS protein most suitable for gene therapy, i.e. preserving regions responsible for the high turnover rate and the efficient plasma membrane localization of the mouse proteinwhile replacing the immunogenic extracellular regions with those of the human ortholog. The porcine NIS gene gives rise to splice variants leading to three active NIS proteins with differences in their C-terminal extremities [4]. However, it is not known if these differences lead to distinct properties (Darrouzet et al., 2014).


How this Key Event Works

Biological state: Sodium/Iodide symporter (NIS) is a key protein in the thyroid function and its role has been thoroughly investigated after the determination of its molecular identity a few decades ago (Dai et al., 1996). NIS is an intrinsic membrane glycoprotein and it belongs to the superfamily of sodium /solute symporters (SSS) and to the family of human transporters SLC5 (De La Vieja, 2000; Jung, 2002). Its molecular weight is 87 kDa and it contains 13 transmembrane domains tha transport 2 sodium cations (Na+) for each iodide anion (I-) into the follicular thyroid cell (Dohan et al., 2003). It has been also shown that many other anions, such as ClO3-, SCN-, NO3-, ReO4-, TcO4- and in a lower extent Br- and BF4-, are acting as NIS substrates and they enter the cell by the same transporter mechanism (Van Sande et al., 2003). It has been also shown that ClO4- is transferred by NIS with high affinity and is considered as one of its most potent inhibitors (Dohan et al., 2007). Most recently, the aryltrifluoroborates were also shown to inhibit NIS function (Lecat-Guillet et al., 2008a). A library of 17,020 compounds was tested by a radioactive screening method with high specificity using transfected mammalian cells (Lecat-Guillet et al., 2008b; 2007) for NIS inhibition evaluation. Further studies with the most powerful inhibitors showed a high diversity in their structure and mode of action (Lindenthal et al., 2009). The regulation of NIS protein function is usually cell- and tissue-specific (Hingorani et al., 2010) and it is done at the transcriptional and posttranslational levels, including epigenetic regulation (Darrouzet et al., 2014; Russo et al., 2011a). One of the major NIS regulators is the thyroid stimulating hormone (TSH), which has been shown to enhance NIS mRNA and protein expression, therefore it can contribute to restore and maintain iodide uptake activity (Saito et al., 1997; Kogai et al., 2000). At the posttranslational level TSH also contributes to NIS regulation but the specific mechanisms that underlie these effects are still under investigation (Riedel et al., 2001).

Biological compartments: NIS protein is mainly found at the basolateral plasma membrane of the thyroid follicular cells (Dai et al., 1996), where it actively mediates the accumulation of iodide that is the main component of thyroid hormone synthesis and therefore is considered as a major regulator of thyroid homeostasis. NIS also mediates active I- transport in extrathyroidal tissues but it is commonly agreed that is regulated and processed differently in each tissue. Functional NIS protein has been found in salivary gland ductal cells (Jhiang et al., 1998; La Perle et al., 2013), in the mammary gland during lactation (Perron et al., 2001; Cho et al., 2000), lung epithelial cells (Fragoso et la., 2004), intestinal enterocytes (Nicola et al., 2009), stomach cells (Kotani et al., 1998), placenta (Bidart et al., 2000) and testicular cells (Russo et al. 2011b). Additionally, contradictory results have been obtained regarding the NIS expression in human kidney tissue (Lacroix et al., 2001; Spitzweg et al., 2001). In the case of the lactating breast, it is suggested that NIS serves the transfer of iodide in the cells and it subsequent accumulation in the milk, thereby supplying newborns with this component during this sensitive developmental period (Tazebay et al., 2000). Additionally, NIS mRNA has been detected in various other tissues, such as colon, ovaries , uterus, and spleen (Perron et al., 2001; Spitzweg et al., 1998; Vayre et al., 1999), but the functional NIS protein and the site of its localization has not been verified.

General role in biology: The NIS is known in the field of thyroidology because of its ability to mediate the active transport of I- into the thyrocytes, which is the first and most crucial step for T3 and T4 biosynthesis (Dohan et al., 2000). NIS is located on the basolateral membrane of the thyrocytes and co-transports 2 sodium ions along with 1 iodide (2:1 stoichiometry). The electrochemical gradient of sodium serves as the driving force for iodide uptake and it is generated and maintained by the Na+/K+ ATPase pump, which is located in the same membrane of the thyrocytes. The iodide molecules, after their active transport in the cytoplasm, are passively translocated in the follicular lumen via the transporter protein pendrin and possibly other unknown efflux proteins that are located on the apical membrane (Bizhanova and Kopp, 2009). Subsequently, the thyroid hormones are synthesized in the follicular lumen by incorporating the accumulated iodide, a process which is significantly suppressed in case of NIS dysfunction or inhibition (reviewed in Spitzweg and Morris, 2010). NIS is the last thyroid-related component to be expressed during development at the 10th gestational week, which temporaly coincides with the onset of thyroid function and hormonogenesis (Szinnai et al., 2007). Albeit the localization of NIS is not fully completed at this stage, the iodide accumulation has already started. Mutations of NIS gene (SLCA5A) cause expression of non-functional NIS molecule leading to inability of the thyrocyte to accumulate iodide (Matsuda and Koshugi, 1997; Pohlenz et al., 1998), a condition called iodide transport defect (ITD). This is a rear autosomic recessive disease, which if not properly treated is clinically identified by congenital hypothyroidism, goiter, low I- uptake, low saliva/plasma I- ratio and mental impairment of varying degrees (Dohan et al., 2003). Up to date 13 mutations have been described in the NIS gene (Spitzweg and Morris, 2010) and each one of them produces mutants with different structure but in all cases non-functional. The extensive study after NIS molecular characterization and the numerous findings have convinced the scientists that is one of the most crucial components of the entire thyroid system. Additionally, after the realization that NIS could be also used as diagnostic and therapeutic tool for thyroid and non-thyroid cancers (Portulano et al., 2013) a new research activity concerning this specific mechanism has been initiated.


How it is Measured or Detected

There are several methods that are used nowadays to detect the functionality of NIS but none of these methods is OECD validated. The most well established methods are the following:

1. Measurement of radioiodide uptake (125I-) in NIS expressing cells. For this method the FRTL5 cell line is the most commonly used, as it endogenously express the NIS protein, but also NIS transfected cell lines have been successfully implemented in many cases (Lecat-Guillet et al., 2007; 2008b; Lindenthal et al., 2009). Once inhibitory activity is identified for a compound then further tests are performed in order to verify that the observed effect is specific due to NIS inhibition. This method has been also adapted in a high throughput format and has been already used for the screening of a chemical library of 17.020 compounds (Lecat-Guillet et al., 2008b).

2. More recently a non-radioactive method has been developed, which has been also adapted in a high throughput format (Waltz et al., 2010). The measurement of iodide uptake in this case is done with an indirect spectophotometric method by using FRTL5 cells. This assay is equally sensitive with the radioiodine detection method.

3. Additionally, a fluorescence-based method has been developed, which uses a variant of the Yellow Fluorescent Protein (YFP) in order to detect the efflux of iodide into the FRTL5 cells. This method needs further optimization, as YFP is not specific for iodide and thus binding of other ionic molecules could affect the results of the assay (Cianchetta et al., 2010; Rhoden et al., 2008; Di Bernarde et al., 2011).


References

Amitai Y, Winston G, Sack J, Wasser J, Lewis M, Blount BC, Valentin-Blasini L, Fisher N, Israeli A, Leventhal A. (2007). Gestational exposure to high perchlorate concentrations in drinking water and neonatal thyroxine levels. Thyroid. 17:843-850.

Bidart JM, Lacroix L, Evain-Brion D, Caillou B, Lazar V, Frydman R, Bellet D, Filetti S, Schlumberger M. (2000). Expression of Na+/I− symporter and Pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab 85:4367–4372.

Bizhanova A, Kopp P. (2009). The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinol 150:1084-1090.

Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL. (2006). Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Env Health Persp. 114:1865-1871.

Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak WE Jr, Mazzaferri EL, Jhiang SM. (2000). Hormonal regulation of radioiodide uptake activity and Na+/I− symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936–2943.

Cianchetta S, di Bernardo J, Romeo G, Rhoden KJ. (2010). Perchlorate transport and ihnibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L. Toxicol App Pharmacol. 243:372-380.

Dai G, Levy O, Carrasco N. (1996). Cloning and characterization of the thyroid iodide transporter. Nature 379:458–460.

Darrouzet E, Lindenthal S, Marcellin D, Pellequer J, Pourcher T. (2014). The sodium/iodide symporter: state of the art of its molecular characterization. Biochim Biophys Acta 1838:244-253.

Dayem M, Basquin C, Navarro V, Carrier P, Marsault R, Chang P, Huc S, Darrouzet E, Lindenthal S, Pourcher T. (2008). Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization. J Endocrinol. 197:95–109.

De La Vieja A, Dohan O, Levy O, Carrasco N. (2000). Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol. Rev. 80: 1083–105.

Di Bernardo J, Iosco C, Rhoden KJ. (2011). Intracellular anion fluorescence assay for sodium/iodide symporter substrates. Analyt Biochem. 415:32-38.

Dohan O, De la Vieja A, Carrasco N. (2000). Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology. Trends Endocrinol Metab. 11:99–105.

Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. (2003). The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev. 24:48–77.

Dohan O, Portulano C, Basquin C, Reyna-Neyra A, Amzel LM, Carrasco N. (2007). The Na+/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proc. Natl. Acad. Sci. U. S. A. 104:20250–20255.

Fragoso MA, Fernandez V, Forteza R, Randell SH, Salathe M, Conner GE. (2004).Transcellular thiocyanate transport by human airway epithelia. J Physiol 561:183–194.

Gerard C, Rigot V, Penel C. (1994). Chloride channel blockers inhibit the Na+/I- symporter in thyroid follicles in culture. Biochem Biophys Res Communic. 204: 1265-1271.

Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ. (2003). The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells. Cancer Gene Ther. 10:14–22.

Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H, Vile R, Harrington K. (2010). The biology of the sodium iodide symporter and its potential for targeted gene delivery. Curr Cancer Drug Targets 10:242–267.

Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL. (1998). An immunohistochemical study of Na+/I− symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139:4416–4419.

Jung H. (2002). The sodium/substrate symporter family: structural and functional features. FEBS Lett. 529:73–77.

Kaminsky SM, Levy O, Garry MT, Carrasco N. (1991). Inhibition of the Na+/I- symporter by harmaline and 3-amino-1-methyl-5H-pyridol(4,3-b)indole acetate in thyroid cells and membrane vesicles. Eur J Biochem. 200:203-207.

Kogai T, Curcio F, Hyman S, Cornford EM, Brent GA, Hershman JM. (2000). Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol 167:125–135.

Kotani T, Ogata Y, Yamamoto I, Aratake Y, Kawano JI, Suganuma T, Ohtaki S. (1998). Characterization of gastric Na+/I− symporter of the rat. Clin Immunol Immunopathol 89:271–278.

La Perle KM, Kim DC, Hall NC, Bobbey A, Shen DH, Nagy R, Wakely PE Jr, Leman A, Jarjoura D, Jhiang SM. (2013). Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid 23:1029-1036.

Lacroix L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M, Bidart JM. (2001). Na+/I- symporter and pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 144:297-302.

Lecat-Guillet N, Ambroise Y. (2008a). Discovery of aryltrifluoroborates as potent sodium/iodide symporter (NIS) inhibitors. Chem Med Chem 3:1207–1209.

Lecat-Guillet N, Merer G, Lopez R, Pourcher T, Rousseau B, Ambroise Y. (2008b). Small-molecule inhibitors of sodium iodide symporter function. Chembiochem 9:889–895.

Lecat-Guillet N, Merer G, Lopez R, Pourcher T, Rousseau B, Ambroise Y. (2007). A 96-well automated radioiodide uptake assay for sodium/iodide symporter inhibitors. Assay Drug Dev Technol 5:535-540.

Lindenthal S, Lecat-Guillet N, Ondo-Mendez A, Ambroise Y, Rousseau B, Pourcher T. (2009). Characterization of small-molecule inhibitors of the sodium iodide symporter. J Endocrinol 200:357–365.

Matsuda A, Kosugi S. (1997). A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82:3966–3971.

Nicola JP, Basquin C, Portulano C, Reyna-Neyra A, Paroder M, Carrasco N. (2009). The Na+/I− symporter mediates active iodide uptake in the intestine. Am J Physiol Cell Physiol 296:C654–C662.

Pearce EN, Lazarus JH, Smyth PPA, He X, Dall'amico D, Parkes AB, Burns R, Smith DF, Maina A, Bestwick JP, Jooman M, Leung AM, Braverman LE. (2010). Perchlorate and thiocyanante exposure and thyroid function in first-trimester pregnant women. J Clin Endocrinol Metab. 95:3207-3215.

Perron B, Rodriguez AM, Leblanc G, Pourcher T. (2001). Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J Endocrinol 170:185–196.

Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S. (1998). Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. J Clin Invest 101:1028-1035.

Portulano C, Paroder-Belenitsky M, Carrasco N. (2014). The Na+/I- symporter (NIS): mechanism and medical impact. Endocr Rev. 35:106-49.

Rhoden KJ, Cianchetta S, Duchi S, Romeo G. (2008). Fluorescence quantitation of thyrocyte iodide accumulation with the yellow fluorescent protein variant YFP-H148Q/I152L. Analyt Biochem. 373:239-246.

Riedel C, Levy O, Carrasco N. (2001). Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 276:21458–21463.

Russo D, Damante G, Puxeddu E, Durante C, Filetti S. (2011a). Epigenetics of thyroid cancer and novel therapeutic targets. J Mol Endocrinol 46:R73–R81.

Russo D, Scipioni A, Durante C, Ferretti E, Gandini L, Maggisano V, Paoli D, Verrienti A, Costante G, Lenzi A, Filetti S. (2011b). Expression and localization of the sodium/iodide symporter (NIS) in testicular cells. Endocrine 40:35–40.

Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T. (1997). Increased expression of the Na+/I− symporter in cultured human thyroid cells exposed to thyrotropin and in Graves’thyroid tissue. J Clin Endocrinol Metab 82:3331–3336.

Selmi-Ruby S, Watrin C, Trouttet-Masson S, Bernier-Valentin F, Flachon V, Munari-Silem Y, Rousset B. (2003). The porcine sodium/iodide symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species. Endocrinology. 144:1074–1085.

Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC. (2001). Expression of the sodium iodide symporter in human kidney. Kidney Int 59:1013-1023.

Spitzweg C, Joba W, Eisenmenger W, Heufelder AE. (1998). Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab. 83:1746–1751.

Spitzweg C, Morris JC. (2010). Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol 322: 56-63. Steinmaus C, Miller MD, Howd R. (2007). Impact of smoking and thiocyanate on perchlorate and thyroid hormone associations in the 2001-2002 National Health and Nutrition Examination Survey. Env Health Persp. 115:1333-1338.

Szinnai G, Lacroix L, Carré A, Guimiot F, Talbot M, Martinovic J, Delezoide AL, Vekemans M, Michiels S, Caillou B, Schlumberger M, Bidart JM, Polak M. (2007). Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetus. J Clin Endocrinol Metab. 92:70–76.

Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Hua Zhao Q, Fu Deng H, Amenta PS, Fineberg S, Pestell RG, Carrasco N. (2000). The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat. Med. 6:871–878.

Tellez RT, Chacon PM, Abarca CR, Blount BC, Van Landingham CB, Crump KS, Gibbs JP. (2005). Long-term environmental exposure to perchlorate through drinking water and thyroid function during pregnancy and the neonatal period. Thyroid. 15:963-975.

Tonacchera M, Pinchera A, Dimida A, Ferrarini E, Agretti P, Vitti P, Santini F, Crump K, Gibbs J. (2004). Relative potencies and additivity of perchlorate, thiocyanate, nitrate and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid. 14:1012-1019.

Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, Wolff J. (2003). Anion selectivity by the sodium iodide symporter. Endocrinology 144:247–252.

Vayre L, Sabourin JC, Caillou B, Ducreux M, Schlumberger M, Bidart JM. (1999). Immunohistochemical analysis of Na-/I- symporter distribution in human extra-thyroidal tissues. Eur J Endocrinol. 141:382–386.

Waltz F, Pillette L, Ambroise Y. (2010). A nonradioactive iodide uptake assay for sodium iodide symporter function. Analytic Biochem. 396:91-95.

Wolff J. (1998). Perchlorate and the thyroid gland. Pharmacol Rev. 50:89-105.

Zhang Z, Liu YY, Jhiang SM. (2005). Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I− symporter and rat Na+/I− symporter. J Clin Endocrinol Metab. 90:6131–6140.


Key Events

Title Short name
Decreased, Thyroidal iodide uptake Decreased, Thyroidal iodide uptake
Decreased, Thyroxine (T4) in neuronal tissue Decreased, Thyroxine (T4) in neuronal tissue
Reduced, Release of BDNF Reduced, Release of BDNF
Decreased, Synaptogenesis Decreased, Synaptogenesis
Decreased, Thyroxin (T4) in serum Decreased, Thyroxin (T4) in serum
Altered, GABAergic interneurons morphology and function Altered, GABAergic interneurons morphology and function
Decreased, Neuronal network function in developing brain Decreased, Neuronal network function in developing brain
Decreased, Thyroid hormone synthesis Decreased, Thyroid hormone synthesis

425: Decreased, Thyroidal iodide uptake

Short Name: Decreased, Thyroidal iodide uptake

Biological Organization

Level of Biological Organization
Cellular

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
rat Rattus norvegicus Strong NCBI
mouse Mus musculus Strong NCBI
Pig Pig Strong NCBI
human Homo sapiens Strong NCBI
Life Stage Applicability
Life Stage Evidence
Birth to <1 month Moderate
Pregnancy Moderate
During brain development Moderate
Sex Applicability
Sex Evidence
Mixed Moderate

Various species express functional NIS  encoded by the following genes: Human SLC5A5 (6528), Mouse Slc5a5 (114479), Rat Slc5a5 (114613), Zebrafish slc5a5 (561445), chicken SLC5A5 (431544), domestic cat SLC5A5 (101092587), dog SLC5A5 (484830), domestic guinea pig Slc5a5 (100714457), naked mole-rat Slc5a5 (101701995), cow SLC5A5 (505310), sheep SLC5A5 (101112315). The encoded protein is responsible for the uptake of iodine in tissues such as the thyroid and lactating breast tissue. The iodine taken up by the thyroid is incorporated into the metabolic regulators triiodothyronine (T3) and tetraiodothyronine (T4). Mutations in this gene are associated with thyroid dyshormonogenesis that significantly influences phenotypic expressions such as severity of hypothyroidism, goiter rates, and familial clustering demonstrating essentiality of NIS function to maintain TH status (Bakker et al., 2000; Spitzweg and Morris, 2010; Ramesh et al., 2016) . Animal studies have also proven that iodine normalizes elevated adrenal corticosteroid hormone secretion and has the ability to reverse the effects of hypothyroidism in the ovaries, testicles and thymus in thyroidectomized rats (Nolan et al., 2000).

 


How this Key Event Works

Iodine (I2) is a non-metallic chemical element which is required for the normal cellular metabolism. It is one of the essential components of the TH, comprising 65% and 58% of T4's and T3's weight, respectively and therefore it is crucial for the normal thyroid function. It is a trace element and a healthy human body contains 15-20 mg of iodine, most of which is concentrated in the thyroid gland (Dunn, 1998). Iodide (I-) that enters the thyroid gland remains in the free state only briefly and subsequently it bounds to the tyrosine residues of thyroglobulin to form the precursors of the thyroid hormones mono-iodinated tyrosine (MIT) or di-iodinated tyrosine (DIT) (Berson and Yalow, 1955). The bounding rate of iodide is 50-100% of the intrathyroidal iodide pool, meaning that only a very small proportion of this element is free in the thyroid and this comes mainly by the deiodination of MIT and DIT.

The body is not able to produce or make iodine, thus the diet is the only source of this element. Iodine is found in nature in various forms, such as inorganic sodium and potassium salts (iodides and iodates), inorganic diatomic iodine and organic monoatomic iodine (Patrick, 2008). Thus, it is widely distributed in the earth's environment but in many regions of the world the soil's iodine has been depleted due to different environmental phenomena. In these regions, the incidence of iodine deficiency is greatly increased (Ahad and Ganie, 2010).

The daily iodine intake of adult humans varies greatly due to the different dietary habits between the different regions on earth (Dunn, 1993). In any case, the ingested iodine is absorbed through the intestine and transported into the plasma to reach the thyroid gland. However, thyroid is not the only organ of the body that concentrates iodide. It has been shown that other tissues have also the ability of iodide concentration, such as the salivary glands, the gastric mucosa, the mammary glands and the choroid plexus, all of which express NIS, the well-known iodine transporter protein (Jhiang et al., 1998; Cho et al., 2000). The thyroid, salivary glands and the gastric mucosa have a common embryologic origin, from the primitive alimentary tract, which may explain the reason of the NIS expression in these tissues. Furthermore, in regards to the gastric mucosa and the breast, there is an obvious value of concentrating iodide, as it is the route for its derivation to the bloodstream and to the breast milk, respectively. The iodide from the circulation will eventually reach the thyroid in order to participate in its most important function, namely the production of thyroid hormones. In contrast, the biological role of iodide in the salivary glands and the choroid plexus is not yet specified, but it is a research area of high interest, as it is believed that it may be involved in important pathways but yet undiscovered.

The most important role of iodine is the formation of the thyroid hormones (T4 and T3). The thyroid actively concentrates the circulating iodide through the basolateral membrane of the thyrocytes by the sodium/iodide symporter protein (NIS). The concentrated thyroid-iodine is oxidized in the follicular cells of the gland and consequently binds to tyrosines to form mono- or di-iodotyrosines (MIT and DIT respectively), being incorporated into thyroglobulin. This newly formed iodothyroglobulin forms one of the most important constituents of the colloid material, present in the follicle of the thyroid unit. If two di-iodotyrosine molecules couple together, the result is the formation of thyroxin (T4). If a di-iodotyrosine and a mono-iodotyrosine are coupled together, the result is the formation of tri-iodothyronine (T3). From the perspective of the formation of thyroid hormone, the major coupling reaction is the di-iodotyrosine coupling to produce T4. Although T3 is more biologically active than T4, the major production of T3 actually occurs outside of the thyroid gland. The majority of T3 is produced by peripheral conversion from T4 in a deiodination reaction involving a specific enzyme which removes one iodine from the outer ring of T4.

A sodium-iodide (Na/I) symporter pumps iodide (I−) actively into the cell, which previously has crossed the endothelium by largely unknown mechanisms. This iodide enters the follicular lumen from the cytoplasm by the transporter pendrin, in a purportedly passive manner. In the colloid, iodide (I−) is oxidized to iodine (I0) by an enzyme called thyroid peroxidase (TPO). Iodine (I0) is very reactive and iodinates the thyroglobulin at tyrosyl residues in its protein chain. In conjugation, adjacent tyrosyl residues are paired together. Thyroglobulin binds the megalin receptor for endocytosis back into the follicular cell. Proteolysis by various proteases liberates thyroxine (T4) and triiodothyronine molecules (T3), which enter the bloodstream where they are bound to thyroid hormone binding proteins. The major thyroid hormone binding protein is thyroxin binding globulin (TBG) which accounts for about 75% of the bound hormone. In order to attain normal levels of thyroid hormone synthesis, an adequate supply of iodine is essential. In iodine sufficient areas, the adult thyroid absorbs 60-80 μg of iodide per day to maintain the thyroid homeostasis (Degroot, 1966). Inadequate amount of iodide results to deficient production of thyroid hormones, which consequently leads to an increase of TSH secretion and goiter, as compensating effect (Delange, 2000). On the other hand, excess iodide could also inhibit TH synthesis (Wolff and Chaikoff, 1948). The proposed mechanism for this latter effect is the possible formation of 2-iodohexadecanal that inhibits the generation of H2O2 and the subsequent oxidation of iodide in the thyroid follicular cells. The lack of oxidized free radicals of iodide affects the reaction with the tyrosine residues of Thyroglobulin (Tg) and the subsequent formation of MIT and DIT (Panneels et al., 1994). During pregnancy, the organism of the mother is also supporting the needs of the foetus and therefore the iodide requirements are greatly increased (Glinoer, 1997). Additionally, small iodine concentrations have been found to have significant antioxidant effects that resembles to ascorbic acid (Smyth, 2003).


How it is Measured or Detected

The radioactive iodine uptake test, or RAIU test, is a type of scan used in the diagnosis of thyroid gland dysfunction. The patient swallows radioactive iodine in the form of capsule or fluid, and its absorption by the thyroid is studied after 4–6 hours and after 24 hours with the aid of a gamma scintillation counter. The percentage of RAIU 24 hours after the administration of radioiodide is the most useful, since this is the time when the thyroid gland has reached the plateau of isotope accumulation, and because it has been shown that at this time, the best separation between high, normal, and low uptake is obtained. The test does not measure hormone production and release but merely the avidity of the thyroid gland for iodide and its rate of clearance relative to the kidney.


References

Ahad F, Ganie SA. (2010). Iodine, iodine metabolism and iodine deficiency disorders revisited. Indian J Endocrinol Metab. 14: 13-17.

Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ. 2000. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). The Journal of clinical endocrinology and metabolism. Oct;85:3708-3712.

Berson SA, Yalow RS. (1955). The iodide trapping and binding functions of the thyroid. J Clin Invest. 34: 186-204.

Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak WE Jr, Mazzaferri EL, Jhiang SM.(2000). Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J Clin Endocrinol Metab. 85:2936-2943.

Degroot LJ.(1966). Kinetic analysis of iodine metabolism. J Clin Endocrinol Metab. 26: 149-173.

Delange F. (2000). Iodine deficiency. In: Braverman L, Utiger R, editors. Werner and Ingbar's the thyroid: a fundamental and clinical text. Philadelphia: JD Lippincott. pp 295-316.

Dunn JT. (1993). Sources of dietary iodine in industrialized countries. In: Delange F, Dunn JT, Glinoer D, editors. Iodine deficiency in Europe. A continuing concern. New York: Plenum press. pp 17-21.

Dunn JT. (1998). What's happening to our iodine? J Clin Endocrinol Metab. 83: 3398-3400. Glinoer D. (1997). The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 18: 404-433.

Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL.(1998). An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology. 139:4416-4419.

Nolan LA, Windle RJ, Wood SA, Kershaw YM, Lunness HR, Lightman SL, Ingram CD, Levy A. (2000). Chronic iodine deprivation attenuates stress-induced and diurnal variation in corticosterone secretion in female Wistar rats. J Neuroendocrinol. 12:1149-1159.

Panneels V, Van den Bergen H, Jacoby C, Braekman JC, Van Sande J, Dumont JE, Boeynaems JM. (1994). Inhibition of H2O2 production by iodoaldehydes in cultured dog thyroid cells. Mol Cell Endocrinol. 102:167-176.

Patrick L. (2008).Iodine:Deficiency and therapeutic considerations. Altern MedRev. 13:166-127.

Ramesh BG, Bhargav PR, Rajesh BG, Devi NV, Vijayaraghavan R, Varma BA.(2016). Genotype‑phenotype correlations of dyshormonogenetic goiter in children and adolescents from South India . I J Endocrinol and Metab. 20: 816-824.

Smyth PA. (2003). Role of iodine in antioxidant defense in thyroid and breast disease. Biofactors. 19:121-130.

Spitzweg C, Morris JC. 2010. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Molecular and cellular endocrinology. Jun 30;322:56-63.

Wolff J, Chaikoff IL. (1948). Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem. 174: 555-564.


280: Decreased, Thyroxine (T4) in neuronal tissue

Short Name: Decreased, Thyroxine (T4) in neuronal tissue

AOPs Including This Key Event


Biological Organization

Level of Biological Organization
Organ

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
chicken Gallus gallus Weak NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Moderate

THs are critical for normal brain development in most vertebrates, primarily documented empirically in mammalian species. However, there is compelling data that demonstrates the need for TH in brain development for many other taxa, including: birds, fish and frogs (Van Herck et al., 2013; Denver, 1998; Power et al., 2001). The most well known non-mammalian action of TH is to induce metamorphosis in amphibians and some fish species. However, there is a fundamental difference in the mechanisms by which T3 affects amphibian metamorphosis vs its role in mammalian brain development (Galton, 1983). In the rat, brain development proceeds, even if defective, despite the absence of TH. By contrast, TH administration to tadpoles induces early metamorphosis, whereas in its absence, tadpoles grow to extremely large size, but the metamorphosis program is never activated (Galton, 1983).


How this Key Event Works

Thyroid hormones are present in brain tissue of most vertebrate species. The amount of THs in brain is known to vary during development and to differ amoung brain regions (Calvo et al., 1990; Kester et al., 2004; Tu et al., 1999). In human cerebral cortex, T3 increases steadily from 13-weeks reaching adult levels by 20 weeks post conception. This occurs despite very low and unchanging levels in fetal serum T3, when fetal serum T4 increases 3-fold over the same period. This indicates that T3 in fetal brain is locally generated from serum-derived T4 via the activity of deiodinases, primarily D2. D2 serves to convert T4 to T3. During this time D3 activity remains very low in cortex, D3 serving to convert T3 to an inactive form, rT3. In contrast, in other brain regions including hippocampus and cerebellum, T3 remains low throughout early and mid-gestation and corresponds with high activity of D3 in these brain regions. In late gestation and after birth, D3 levels drop in hippocampus and cerebellum with a corresponding increase in T3 concentrations (Kester et al., 2004).

A similar spatial and temporal profile of deiodinase activity and corresponding brain hormone concentrations has been observed in rodent brain (Calvo et al., 1990; Tu et al., 1999). In the rat, either whole brain or cortex have been preferentially assessed due to the low levels of hormones present and the small tissue volumes in the fetal rat brain making quantitification difficult. Brain T3 and T4 rise in parallel from gestational day 10 to gestational day 20 in rat. They are typically both quite low tuntil gestational 17 with steep increases between GD18 and GD20 corresponding to the onset of fetal thyroid function (Calvo et al., 1990; Ruiz de Ono et al., 1988; Obergon et al., 1981). Just before birth, brain T3 and T4 concentrations are about one-third to one-half that of adult brain. Brain development in the early postnatal period in rat is roughly equivalent to the 3rd trimester in humans such that adult levels of T3 and T4 in brain are not reached in rodents until the 2nd-3rd postnatal week.

For THs to gain access to brain tissue they need to cross the blood brain barrier (BBB) which regulates the active transport of TH into neurons. Many transporter proteins have been identified, and the monocarboxylate transporters (Mct8, Mct10) and anion-transporting polypeptide (OATP1c1) show the highest degree of affinity towards TH and are prevalent in brain (Jansen et al., 2007; Mayer et al., 2014). Transporters express a distinct distribution pattern that varies by tissue and age (Friesema et al., 2005; Henneman et al., 2001; Visser et al., 2007; Heuer et al., 2005; Muller and Heuer, 2007). Although several transporters have been identified, current knowledge of cell specific profile of transporters is limited. Most of the hormone transported across the blood brain barrier in in the form of T4, primarily thourhg the OATP1c1 transporter, and into the astrocyte (Visser and Visser, 2012; Sugiyama et al., 2003; Tohyama et al., 2004). Within the astrocyte, T4 is converted into T3 via the local activity of deiodinase 2 (D2) (Guadano-Ferraz et al., 1997). A small amount of T3 may cross the blood brain barrier directly via the T3-specific transporter, MCT8 (Heuer et al., 2005). Although in mature brain T3 derives partially from the circulation and from the deiodination of T4, in the fetal brain T3 is exclusively a product of T4 deiodination (Calvo et al., 1990; Grijota-Martinez et al., 2011). In both cases, only the required amount of T3 is utilized in neurons and the excess is degraded by the neuron-specific deiodinase D3 (Tu et al., 1999; St. Germain et al., 2009; Hernandez et al., 2010). Both deiodinase and transporter expression in brain peak in different brain regions at different times in fetal and neonatal life (Kester et al., 2004; Bates et al., 1999; Muller and Heuer, 2014; Heuer, 2007). Collectively, these spatial and temporal patterns of transporter expression and deiodinase activity provide exquisite control of brain T3 available for nuclear receptor activation and regulated gene expression.


How it is Measured or Detected

Radioimmunoassays (RIAs) are commonly used to detect TH in the brain (e.g., Morreale de Escobar, 1985; Calvo et al., 1990; Morse et al., 1996; Bansal et al., 2005; Gilbert et al., 2013). The method (and minor variants) is well established in the published literature. However, it is not available in a simple 'kit' and requires technical knowledge of RIAs, thus has not been used in most routine toxicology studies. Evaluations in neuronal tissue are complicated by the difficulty of the fatty matrix, heterogeneity of regions within the brain, and low tissue concentrations and small tissue amounts especially in immature brain. Two analytical techniques, LC-tandom mass spectrometry (LC/MS-MS), and LC–inductively coupled plasma–mass spectrometry (LC–ICP–MS) have recently been used to measure brain concentrations of TH. The latter (Simon et al., 2002) has proven capable of measuring very low levels in whole-body homogenates of frog tadpoles at different developmental stages. The assay detects I–, MIT, DIT, T4, T3, and rT3. More recently, Wang and Stapleton (2010) and Donzelli et al. (2016) used liquid chromatography-tandem mass spectrometry for the simultaneous analysis of five THs including thyroxine (T4), 3,3′,5-triidothyronine (T3), 3,3′,5′-triiodothyronine (rT3; reverse T3), 3,3′-diiodothyronine (3,3′-T2), and 3,5-diiodothyronine (3,5-T2) in serum and a variety of tissues including brain. These analytical methods require expensive equipment and technical expertise and as such are not routinely used.


References

Bansal R, You SH, Herzig CT, Zoeller RT (2005). Maternal thyroid hormone increases HES expression in the fetal rat brain: an effect mimicked by exposure to a mixture of polychlorinated biphenyls (PCBs). Brain Res Dev Brain Res 156:13-22.

Bates JM, St Germain DL, Galton VA. Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology. 1999 Feb;140(2):844-51.

Bernal J. (2013). Thyroid Hormones in Brain Development and Function. www.thyroidmanager.org.

Calvo R, Obregón MJ, Ruiz de Oña C, Escobar del Rey F, Morreale de Escobar G. (1990). Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3′-triiodothyronine in the protection of the fetal brain. J. Clin. Invest. 86:889-899.

Denver, RJ 1998 The molecular basis of thyroid hormone-dependent central nervous system remodeling during amphibian metamorphosis. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 119:219-228.

Donzelli R, Colligiani D, Kusmic C, Sabatini M, Lorenzini L, Accorroni A, Nannipieri M, Saba A, Iervasi G, Zucchi R. Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat. Eur Thyroid J. 2016 Mar;5(1):27-34.

Friesema EC, Jansen J, Milici C, Visser TJ (2005) Thyroid hormone transporters. Vitam Horm 70:137-167.

Galton VH 1983 Thyroid hormone action in amphibian metamorphosis. In: Oppenheimer JH, Samuels HH (eds) Molecular Basis of Thyroid Hormone Action. Academic Press, New York, pp 445–483.

Gilbert ME, Hedge JM, Valentin-Blasini L, Blount BC, Kannan K, Tietge J, Zoeller RT, Crofton KM, Jarrett JM, Fisher JW (2013) An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome. Toxicol Sci 132:177-195.

Grijota-Martinez C, Diez D, Morreale de Escobar G, Bernal J, Morte B. (2011). Lack of action of exogenously administered T3 on the fetal rat brain despite expression of the monocarboxylate transporter 8. Endocrinology. 152:1713-1721.

Guadano-Ferraz A, Obregon MJ, St Germain DL, Bernal J. (1997). The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci USA. 94: 10391–10396.

Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ. (2001). Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev. 22:451-476.

Hernandez A, Quignodon L, Martinez ME, Flamant F, St Germain DL. Type 3 deiodinase deficiency causes spatial and temporal alterations in brain T3 signaling that are dissociated from serum thyroid hormone levels. Endocrinology. 2010 Nov;151(11):5550-8.

Heuer H. (2007). The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab. 21:265–276.

Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K. (2005). The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146:1701–1706.

Jansen J, Friesema EC, Kester MH, Milici C, Reeser M, Gruters A, Barrett TG, Mancilla EE, Svensson J, Wemeau JL, Busi da Silva Canalli MH, Lundgren J, McEntagart ME, Hopper N, Arts WF, Visser TJ (2007) Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab 92:2378-2381.

Kester MH, Martinez de Mena R, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, Hume R, Morreale de Escobar G. (2004). Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 89:3117–3128.

Mayer S, Müller J, Bauer R, Richert S, Kassmann CM, Darras VM, Buder K, Boelen A, Visser TJ, Heuer H. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. J Clin Invest. 2014 May 1;124(5):1987-99.

Morse DC, Wehler EK, Wesseling W, Koeman JH, Brouwer A. Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254).Toxicol Appl Pharmacol. 1996 Feb;136(2):269-79.

Müller J, Heuer H. Expression pattern of thyroid hormone transporters in the postnatal mouse brain. Front Endocrinol (Lausanne). 2014 Jun 18;5:92.

Obregon MJ, Mallol J, Escobar del Rey F, Morreale de Escobar G. (1981). Presence of l-thyroxine and 3,5,3-triiodo-l-thyronine in tissues from thyroidectomised rats. Endocrinology 109:908-913.

Power DM, Llewellyn L, Faustino M, Nowell MA, Björnsson BT, Einarsdottir IE, Canario AV, Sweeney GE. Thyroid hormones in growth and development of fish. Comp Biochem Physiol C Toxicol Pharmacol. 2001 Dec;130(4):447-59.

Ruiz de Oña C, Obregón MJ, Escobar del Rey F, Morreale de Escobar G. Developmental changes in rat brain 5'-deiodinase and thyroid hormones during the fetal period: the effects of fetal hypothyroidism and maternal thyroid hormones. Pediatr Res. 1988 Nov;24(5):588-94.

Simon R, Tietge JE, Michalke B, Degitz S, Schramm KW.Iodine species and the endocrine system: thyroid hormone levels in adult Danio rerio and developing Xenopus laevis. Anal Bioanal Chem. 2002 Feb;372(3):481-5.

St Germain DL, Galton VA, Hernandez A. (2009). Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology. 150:1097-107.

Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, Sugiyama Y. (2003). Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood–brain barrier: high affinity transporter for thyroxine. J Biol Chem. 278:43489–43495.

Tohyama K, Kusuhara H, Sugiyama Y. (2004). Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology. 145: 4384–4391.

Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM, Larsen PR. (1999). Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology. 140: 784–790.

Van Herck SL, Geysens S, Delbaere J, Darras VM. Regulators of thyroid hormone availability and action in embryonic chicken brain development. Gen Comp Endocrinol. 2013 Sep 1;190:96-104. doi: 10.1016/j.ygcen.2013.05.003. Epub 2013 May 21.

Visser EW, Visser TJ. (2012). Finding the way into the brain without MCT8. J Clin Enodcrinol Metab. 97:4362-4365.

Visser WE, Friesema EC, Jansen J, Visser TJ. (2007). Thyroid hormone transport by monocarboxylate transporters. Best Pract Res Clin Endocrinol Metab. 21:223–236.

Wang, D. and Stapleton, HM. (2010) Analysis of thyroid hormones in serum by liquid chromatography -tandem mass spectrometry. Anal Bioanal Chem. 2010 Jul; 397(5): 1831–1839.


381: Reduced, Release of BDNF

Short Name: Reduced, Release of BDNF

Biological Organization

Level of Biological Organization
Molecular

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
mouse Mus musculus Strong NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Strong

BDNF plays a critical role in normal brain development in most vertebrates, primarily documented empirically in mammalian species. Klein et al. (2011) examined blood, serum, plasma and brain-tissue and measured BDNF levels in three different mammalian species: rat, pig, and mouse, using an ELISA method (Aid et al., 2007), whereas Trajkovska et al. 2007 determined BDNF levels in human blood.

There is compelling data that demonstrates the role  of  BDNF  in brain development for many other taxa, including fish where it acts as neurotrophic factor in controlling cell proliferation (D'Angelo L et al., 2014; Heinrich and Pagtakhan, 2004) and  birds where BDNF influences development of the brain area that involved in the song control (Brenowitz 2013) and  the addition of new neurons to a cortical nucleus in adults . In the Xenopus visual system, BDNF acts as neurotrophic factor that mediates synaptic differentiation and maturation of the retinotectal circuit through cell autonomous TrkB signaling on retinal ganglion cells (Sanchez et al., 2006; Marshak et al., 2007).


How this Key Event Works

Biological state: BDNF belongs to a family of closely related neurotrophic factors named neurotrophins and is widely expressed in the developing and mature CNS. In the rodent cortex, postnatal BDNF expression is initially low but slowly increases to reach high levels around weaning. Therefore, BDNF expression peaks at a time when both structural and functional maturation of cortical circuitry occurs. During postnatal development, BDNF levels are dynamically regulated, in part by neuronal activity dependent mechanisms (Waterhouse and Xu, 2009). Glutamate has been shown to increase the transcription and release of BDNF. Indeed, BDNF is synthesized, stored and released from glutamatergic neurons (Lessmann et al., 2003).

Biological compartments: BDNF initially is synthesized as precursor proteins (proBDNF), which is processed intracellularly to be transformed in its mature form (mBDNF) after proteolytically cleaved in the synaptic cleft by plasmin which is a protease activated by tissue plasminogen activator (tPA) (Cohen-Cory et al., 2010). proBDNF is constantly secreted while tPA release and mBDNF production depends on neuronal excitation (Head et al., 2009). Storage and activity-dependent release of BDNF has been demonstrated in both dendrites and axon terminals (Waterhouse and Xu, 2009). More specifically, in hippocampus, BDNF appears to be stored in dendritic processes of neurons (Balkowiec and Katz, 2002). BDNF is abundant in cerebellum and cortex and has also been measured in cerebrospinal fluid (CSF) (Zhang et al., 2008), whole blood, plasma, serum (plasma without clotting factors) and platelets (Trajkovska et al., 2007). BDNF has been found to be produced by astrocytes under both physiological and pathological conditions (Endo, 2005; Coco et al., 2013; Nelson and Alkon, 2014).

In humans, mBDNF is sequestered in platelets, consequently BDNF can reach all tissues and organs. Lymphocytic cells have been shown to express BDNF in vitro similarly to eosinophils, dendritic cells, and endothelial cells. The visceral and airway epithelium are also significant sources of BDNF. Female reproductive system including ovaries, placenta and uterus also express BDNF (Wessels et al., 2014).

General role in biology: The biological functions of mBDNF are mediated by binding to tyrosine kinase B (TrkB) receptor that leads to the activation of three major intracellular signalling pathways, including MAPK, PI3K and PLCγ1 (Soulé et al., 2006). TrkB-mediated signaling regulates gene transcription in the nucleus through the activation of several transcription factors. These genes are involved in neurite outgrowth, synaptogenesis, synapse maturation and stabilization (Pang et al., 2004; Lu et al., 2005; Nelson and Alkon, 2014).

On the other hand, proBDNF binds to the p75 neurotrophin receptor (p75NTR) and activates RhoA, a small GTPase that regulates actin cytoskeleton polymerization leading to inhibition of axonal elongation, growth cone collapse, and apoptosis (Dubreuil et al., 2003; Yamauchi et al., 2004; Head et al., 2009).


How it is Measured or Detected

Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?


No OECD methods are available to measure BDNF protein and mRNA levels. Depending on the tissue or fluid measurements distinct methods are used.

Brain tissue: BDNF protein levels can be measured by commercial available antibody sandwich ELISA kits, Western blotting, immunohistochemistry and immunofluorescence. BDNF primers for different exons are available to determine mRNA levels by RT-PCR. The Bdnf gene consists of multiple alternative exons (ten in human, eight in rodents and six in lower vertebrates), and a single exon coding for the entire pro-BDNF protein (Cohen-Cory et al., 2010).

Cerebro-spinal fluid (CSF): There are available commercial antibody sandwich ELISA kits (Trajkovska et al., 2007) and immunobead-based multiplex assays for high throughput screening (Zhang et al., 2008).

Whole blood, serum, plasma and platelets: There are several commercial double antibody sandwich ELISA kits that can be used for identification of BDNF levels in biological fluids (Trajkovska et al., 2007).

Methodological considerations that have to be taken into account during sample preparation and measurement of BDNF by ELISA have been recently reviewed in Elfving et al. 2010. A study measuring BDNF by a commercially available ELISA kit in various tissues and biological liquids derived from distinct species revealed that BDNF is undetectable in mouse blood and pig plasma (Klein et al., 2011). This study also showed that in most cases BDNF levels are comparable to levels reported in humans and that there is positive correlation between blood BDNF levels and hippocampal BDNF levels in rats and pigs (Klein et al., 2011).


References


Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res. 85: 525-535.

Balkowiec A, Katz DM. (2002) Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci. 22: 10399-10407.

Brenowitz EA. (2013) Testosterone and brain-derived neurotrophic factor interactions in the avian song control system. Neuroscience 239: 115-123.

Coco M, Caggia S, Musumeci G, Perciavalle V, Graziano AC, Pannuzzo G, Cardile V. (2013) Sodium L-lactate differently affects brain-derived neurothrophic factor, inducible nitric oxide synthase, and heat shock protein 70 kDa production in human astrocytes and SH-SY5Y cultures.J Neurosci Res. 91: 313-320.

Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 70: 271-288.

D'Angelo L, De Girolamo P, Lucini C, Terzibasi ET, Baumgart M, Castaldo L, Cellerino A (2014). Brain-derived neurotrophic factor: mRNA expression and protein distribution in the brain of the teleost Nothobranchius furzeri. J Comp Neurol. 1;522(5):1004-30.

Dubreuil CI, Winton MJ, McKerracher L. (2003) Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol. 162: 233-243.

Elfving B, Plougmann PH, Wegener G. (2010) Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions. J Neurosci Methods 187: 73-77.

Endo T. (2005) Glycans and glycan-binding proteins in brain: galectin-1-induced expression of neurotrophic factors in astrocytes. Curr Drug Targets. 6:427-436.

Head BP, Patel HH, Niesman IR, Drummond JC, Roth DM, Patel PM. (2009) Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology 110: 813-825.

Heinrich G, Pagtakhan CJ. (2004) Both 5' and 3' flanks regulate Zebrafish brain-derived neurotrophic factor gene expression. BMC Neurosci. 5: 19.

Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S. (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 14: 347-353.

Lessmann V, Gottmann K, Malcangio M. (2003) Neurotrophin secretion: current facts and future prospects. Prog Neurobiol. 69: 341-374.

Lu B, Pang PT, Woo NH. (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci. 6: 603-614.

Marshak S, Nikolakopoulou AM, Dirks R, Martens GJ, Cohen-Cory S (2007)Cell-autonomous TrkB signaling in presynaptic retinal ganglion cells mediates axon arbor growth and synapse maturation during the establishment of retinotectal synaptic connectivity. J Neurosci 27:2444 –2456.

Nelson TJ, Alkon DL. (2014) Molecular regulation of synaptogenesis during associative learning and memory. Brain Res. pii: S0006-8993(14)01660-6. doi: 10.1016/j.brainres.2014.11.054.

Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science. 306: 487-491.

Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics. 90: 397-406.

Sanchez AL, Matthews BJ, Meynard MM, Hu B, Javed S, Cohen Cory S (2006) BDNF increases synapse density in dendrites of developing tectal neurons in vivo. Development 133:2477–2486.

Soule´ J, Messaoudi E, Bramham CR. (2006) Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans. 34 :600-604.

Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM. (2007) Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull. 73: 143-149.

Waterhouse EG, Xu B. (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci. 42: 81-89.

Wessels JM, Wu L, Leyland NA, Wang H, Foster WG. (2014) The Brain-Uterus Connection: Brain Derived Neurotrophic Factor (BDNF) and Its Receptor (Ntrk2) Are Conserved in the Mammalian Uterus. PLoS ONE 9: e94036.

Yamauchi J, Chan JR, Shooter EM. (2004) Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases. Proc Natl Acad Sci U S A. 101: 8774-8779.

Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. (2008) CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 129: 526-529.


385: Decreased, Synaptogenesis

Short Name: Decreased, Synaptogenesis

Biological Organization

Level of Biological Organization
Cellular

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
mouse Mus musculus Strong NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Strong

The mechanisms governing synapse formation is considered conserved among both vertebrates and invertebrates (Munno and Syed, 2003). Invertebrates have served as simple animal models to study synapse formation. Indeed, Colón-Ramos (2009) has recently reviewed the early developmental events that take place in the process of synaptogenesis pointing out the importance of this process in neural network formation and function. The experimental evaluation of synaptogenesis has been performed using invertebrates and in particular C. elegans and Drosophila as well as vertebrates (Colón-Ramos, 2009).

This vulnerable period of synaptogenesis appears to happen in different developmental stages across species. For example, in rodents primarily synaptogenesis occurs during the first two weeks after birth (Bai et al., 2013). For rhesus monkeys, this period ranges from approximately 115-day gestation up to PND 60 (Bai et al., 2013). In humans, it starts from the third trimester of pregnancy and continues 2-3 years following birth (Bai et al., 2013).


How this Key Event Works

Biological state: Synaptogenesis is a multi-step process that is crucial for brain development and involves the formation of synapses. It follows axonal migration, at which stage presynaptic and postsynaptic differentiation occurs (Garner et al., 2002). "Synaptic assembly" that refers to the gathering of the appropriate components and "synaptic formation" that is defined by the mechanisms involved in recruitment of molecules required for differentiation, stabilization and maturation of synapse, are the main phases that characterise synaptogenesis (Colón-Ramos, 2009). Elimination is a physiological step involved in synaptogenesis regarding the synapses that fail to get stabilised and mature.

The first step is the recognition and the establishment of contact between an axon and a dendritic spine in which pre- and postsynaptic neurons play important role. The presynaptic differentiation occurs followed by excretion of neurotransmitters that bind to appropriate receptors located on the target spine. However, a postsynaptic neuron does not passively receive guidance from a presynaptic axon but are the same dendritic filopodia that gradually are transformed into spines that select and engage their presynaptic neurons. The transformation of dendritic filopodia into dendritic spines that involves the expression of the whole postsynaptic machinery such as postsynaptic density (PSD), receptor subunits, scaffolding proteins and actin cytoskeleton, is the first step to give nascent synapses. However, to become functional and mature these synapses need an important number of cell-cell interactions, including stimulation from glutamatergic synapses as well as the influence of neurotrophic factors (Munno and Syed, 2003).

However, all this is true for glutamatergic synapses because GABAergic synapses do not appear in dendritic spines, but rather form on dendritic shafts, nerve cell somata and axon initial segments. These inhibitory synapses besides their distinct location are also structurally different compared to excitatory synapses (reviewed in Gatto and Broadie, 2010).


Biological compartments: Synaptogenesis is spatially and temporally strictly controlled process. It does not happen in a uniform way in all brain regions and there important differences between the times of appearance of the main two types of synapses (reviewed in Erecinska et al., 2004). For example, in rat hippocampus excitatory synapses are well established or fully mature within the two first postnatal weeks, whereas inhibitory synapses cannot be found prior to PND 18, after which it increases steadily to reach adult levels at PND 28. In addition, in rat neostriatal neurons the excitatory responses to both cortical and thalamic stimuli can be observed by PND 6, but the long-lasting hyperpolarization and late depolarization is never seen before PND 12.

Structural remodelling of synapses and formation of new synaptic contacts has been postulated as a possible mechanism underlying the late phase of long-term potentiation (LTP), a form of plasticity which is involved in learning and memory. LTP induction results in a sequence of morphological changes consisting of a transient remodelling of the postsynaptic membrane followed by a marked increase in the proportion of axon terminals contacting two or more dendritic spines. Three-dimensional reconstruction revealed that these spines arose from the same dendrite. As pharmacological blockade of LTP prevented these morphological changes, it is suggested that LTP is associated with the formation of new, mature and probably functional synapses contacting the same presynaptic terminal and thereby duplicating activated synapses (Erik et al., 2006).

In human, synaptogenesis does not happen at the same time in all brain regions, as the prefrontal cortex lags behind in terms of synapse formation compared to the auditory and visual cortices. In contrast, synaptogenesis appears to proceed concurrently in different brain areas for rhesus monkey (Erecinska et al., 2004).


General role in biology: The period of rapid synaptogenesis or the so-called brain growth spurt is considered one of the most important processes that take place during brain development (Garner et al., 2002). This process is crucial not only in neurodevelopment but also plays a vital role in synaptic plasticity, learning and memory and adaptation throughout life. Without this process no complex brain network can be established as synapse is the fundamental unit of connectivity and communication between neurons (Tau and Peterson, 2010). Cell adhesion represents the most direct way of coordinating synaptic connectivity in the brain. Recent evidence highlights the importance of a trans-synaptic interaction between postsynaptic neuroligins and presynaptic neurexins. These transmembrane molecules bind each other extracellularly to promote adhesion between dendrites and axons, facilitating synapse establishment (Dean and Dresbach, 2006). Furthermore, the number of excitatory versus inhibitory synapses created at single neuron dictates neuronal excitability and function (Schummers et al., 2002).


How it is Measured or Detected

Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?

There is no OECD advised method for measuring synaptogenesis.

Anatomical methods can be used to structurally estimate the number of excitatory or inhibitory synapses. Immunostaining can be employed with specific antibodies that recognize vesicular glutamate transporters (VGLUTs) and the postsynaptic density protein-95 kDa (PSD-95) that are characteristic of excitatory synapses, while inhibitory synapses are identified by the presence of the vesicular GABA (VGAT) and vesicular inhibitory amino acid (VIAAT) transporters and the postsynaptic adaptor protein gephryin (Gatto and Broadie, 2010). There are commercial available synaptogenesis assay kits that rely on the immunostaining of cells with MAP-2, PSD-95 and synaptophysin. Some other presynaptic (Bassoon) and postsynaptic (ProSAP1/Shank2) markers have been suggested and showed to correlate well with the ultrastructural studies in cultured hippocampus primary cells (Grabrucker et al., 2009). Electron microscopy can also be applied to assess the prevalence of excitatory and inhibitory synapses amongst convergent contacts (Megias et al., 2001). Recently, a high content image analysis based on RNAi screening protocols has been suggested as a useful tool to create imaging algorithm for use in both in vitro and in vivo synaptic punctae analysis (Nieland et al., 2014).


References


Bai X, Twaroski D, Bosnjak ZJ. (2013) Modeling anesthetic developmental neurotoxicity using human stem cells. Semin Cardiothorac Vasc Anesth. 17: 276-287.

Colón -Ramos DA. (2009) Synapse formation in developing neural circuits. Curr Top Devel Biol. 87: 53-79.

Dean C, Dresbach T. (2006) Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci. 29:21-29.

Erecinska M, Cherian S, Silver IA. (2004) Energy metabolism in mammalian brain during development. Prog Neurobiol. 73: 397-445.

Erik I. Charyc, Barbara F. Akum, Joshua S. Goldber, Rebecka J. Jörnsten, Christopher Rongo, James Q. Zheng and Bonnie L. Firestein. Activity-Independent Regulation of Dendrite Patterning by Postsynaptic Density Protein PSD-95. Journal of Neuroscience 2006, 26(40): 10164-10176.

Garner CC, Zhai RC, Gundelfinger ED, Ziv NE. (2002) Molecular mechanisms of CNS synaptogenesis. Cell Press 25: 243-250.

Gatto CL, Broadie K. (2010) Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Syn Neurosci. 2: 4.

Grabrucker A, Vaida B, Bockmann J, Boeckers TM. (2009) Synaptogenesis of hippocampal neurons in primary cell culture. Cell Tissue Res. 338: 333-341.

Megias M, Emri Z, Freund TF, Gulyas AI. (2001) Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102: 527-540.

Munno DW, Syed NI. (2003) Synaptogenesis in the CNS: an odyssey from wiring together to firing together. J Physiol. 552: 1-11.

Nieland TJF, Logan DJ, Saulnier J, Lam D, Johnson C, et al. (2014) High Content Image Analysis Identifies Novel Regulators of Synaptogenesis in a High-Throughput RNAi Screen of Primary Neurons. PLoS ONE. 9: e91744.

Schummers J, Mariño J, Sur M. (2002) Synaptic integration by V1 neurons depends on location within the orientation map. Neuron. 36: 969-978.

Tau GZ, Peterson BS. (2010) Normal Development of Brain Circuits. Neuropsychopharmacology 35: 147-168.


281: Decreased, Thyroxin (T4) in serum

Short Name: Decreased, Thyroxin (T4) in serum

AOPs Including This Key Event


Biological Organization

Level of Biological Organization
Tissue

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
mouse Mus musculus Strong NCBI
African clawed frog Xenopus laevis Strong NCBI
chicken Gallus gallus Moderate NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Strong

The overall evidence supporting taxonomic applicability is strong. THs are evolutionarily conserved molecules present in all vertebrate species (Hulbert, 2000; Yen, 2001). Moreover, their crucial role in amphibian and larbean metamorphoses is well established (Manzon and Youson, 1997; Yaoita and Brown, 1990; Furlow and Neff, 2006). Their existence and importance has also been described in many different animal and plant kingdoms (Eales, 1997; Heyland and Moroz, 2005), while their role as environmental messenger via exogenous routes in echinoderms confirms the hypothesis that these molecules are widely distributed among the living organisms (Heyland and Hodin, 2004). However, the role of TH in the different species depends on the expression and function of specific proteins (e.g receptors or enzymes) under TH control and may vary across species and tissues. As such extrapolation regarding TH action across species should be done with caution.

With few exceptions, vertebrate species have circulating T3 and T4 that are bound to transport proteins in blood. Clear species differences exist in serum transport proteins (Dohler et al., 1979; Yamauchi and Isihara, 2009). There are three major transport proteins in mammals; thyroid binding globulin (TBG), transthyretin (TTR), and albumin. In adult humans, the percent bound to these proteins in adult humans is about 75, 15 and 10 percent, respectively (Schussler 2000). In contrast, the majority of THs are bound to TTR in adult rats. And thyroid binding proteins are developmentally regulated in rats. Thyroxine binding globulin is expressed in rats until approximately postnatal day (PND) 60, with peak expression occurring during weaning (Savu et al., 1989). Low low levels of TBG persist into adult ages in rats and can be experimentally induced by hypothyroidism, malnutrition, or caloric restriction (Rouaze-Romet et al., 1992). While these species differences impact hormone half-life (Capen, 1997) and possibly regulatory feedback mechanisms, there is little information on quantitative dose-response relationships. SerumTHs are still regarded as the most robusts measurable key event causally linked to downstream adverse outcomes.


How this Key Event Works

There are two biological active thyroid hormones (THs) in serum, triiodothyronine (T3) and thyroxine (T4), and a few inactive iodothyronines (rT3, 3,5-T2), which are all derived from the modification of tyrosine molecules (Zoeller et al., 2007). However, the plasma concentrations of the other iodothyronines are significantly lower than those of T3 and T4.

The circulatory system serves as the major transport and delivery system for TH delivery to tissues. The majority of THs in the blood are bound to transport proteins (Bartalena and Robbins, 1993). In serum, it is the unbound, or ‘free’ form of the hormone that is active and available for transport into tissues. Free hormones are approximately 0.03 and 0.3 percent for T4 and T3, respectively. There are major species differences in the predominant binding proteins and their affinities for THs (see below). However, there is broad agreement that changes in serum concentrations of THs is diagnostic of thyroid disease or chemical-induced disruption of thyroid homeostasis (Zoeller et al., 2007).

In rodents, serum TH are low in the fetal circulation, increasing as the fetal thyroid gland becomes functional on gestational day 17, just prior to birth on gestational day 22. After birth serum hormones increase steadily, peaking at two weeks, and falling slightly to adult levels by postnatal day 21 (Zoeller et al., 2007).


How it is Measured or Detected

Serum T3 and T4 can be measured as free (unbound) or total (bound + unbound). Free hormone are considered more direct indicators of T4 and T3 activities in the body, but in animal studies, total T3 and T4 are typically measured as the concentrations of free hormone are very low and difficult to detect. Historically, the most widely used method in toxicology is radioaminoassay (RIA). The method is routinely used in rodent endocrine and toxicity studies. The ELISA method is a commonly used as a human clinical test method. Least common is analytical determination of iodothyronines (T3, T4, rT3, T2) and their conjugates, though methods employing HLPC and mass spectrometry exist (Hornung et al., 2015; DeVito et al., 1999; Spencer, 2013).

Any of these measurements should be evaluated for fit-for-purpose, relationship to the actual endpoint of interest, repeatability, reproducibility, and lower limits of quantification. All three of the methods summarized above would be fit-for-purpose, depending on the number of samples to be evaluated and the associated costs of each method. Both RIA and ELISA measure THs by an indirect methodology, whereas analytical determination is the most direct measurement available. All of these methods, particularly RIA, are repeatable and reproducible.


References

Bartalena L, Robbins J.Thyroid hormone transport proteins.Clin Lab Med. 1993 Sep;13(3):583-98. Bassett JH, Harvey CB, Williams GR. (2003). Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol. 213:1-11.

Capen CC. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol. 1997 25(1):39-48.

DeVito M, Biegel L, Brouwer A, Brown S, Brucker-Davis F, Cheek AO, Christensen R, Colborn T, Cooke P, Crissman J, Crofton K, Doerge D, Gray E, Hauser P, Hurley P, Kohn M, Lazar J, McMaster S, McClain M, McConnell E, Meier C, Miller R, Tietge J, Tyl R. (1999). Screening methods for thyroid hormone disruptors. Environ Health Perspect. 107:407-415.

Döhler KD, Wong CC, von zur Mühlen A (1979). The rat as model for the study of drug effects on thyroid function: consideration of methodological problems. Pharmacol Ther B. 5:305-18.

Eales JG. (1997). Iodine metabolism and thyroid related functions in organisms lacking thyroid follicles: Are thyroid hormones also vitamins? Proc Soc Exp Biol Med. 214:302-317.

Furlow JD, Neff ES. (2006). A developmental switch induced by thyroid hormone: Xenopus laevis metamorphosis. Trends Endocrinol Metab. 17:40–47.

Heyland A, Hodin J. (2004). Heterochronic developmental shift caused by thyroid hormone in larval sand dollars and its implications for phenotypic plasticity and the evolution of non-feeding development. Evolution. 58: 524-538.

Heyland A, Moroz LL. (2005). Cross-kingdom hormonal signaling: an insight from thyroid hormone functions in marine larvae. J Exp Biol. 208:4355-4361.

Hornung MW, Kosian P, Haselman J, Korte J, Challis K, Macherla C, Nevalainen E, Degitz S (2015) In vitro, ex vivo and in vivo determination of thyroid hormone modulating activity of benzothiazoles. . Toxicol Sci 146:254-264.

Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev Camb Philos Soc. 2000 Nov;75(4):519-631. Review.

Manzon RG, Youson JH. (1997). The effects of exogenous thyroxine (T4) or triiodothyronine (T3), in the presence and absence of potassium perchlorate, on the incidence of metamorphosis and on serum T4 and T3 concentrations in larval sea lampreys (Petromyzon marinus L.). Gen Comp Endocrinol. 106:211-220.

Rouaze-Romet M, Savu L, Vranckx R, Bleiberg-Daniel F, Le Moullac B, Gouache P, Nunez EA. 1992. Reexpression of thyroxine-binding globulin in postweaning rats during protein or energy malnutrition. Acta Endocrinol (Copenh).127:441-448.

Savu L, Vranckx R, Maya M, Gripois D, Blouquit MF, Nunez EA. 1989. Thyroxine-binding globulin and thyroxinebinding prealbumin in hypothyroid and hyperthyroid developing rats. BiochimBiophys Acta. 992:379-384.

Schussler, G.C. (2000). The thyroxine-binding proteins. Thyroid 10:141–149.

Spencer, CA. (2013). Assay of thyroid hormone and related substances. In De Groot, LJ et al. (Eds). Endotext. South Dartmouth, MA Yamauchi K1, Ishihara A. Evolutionary changes to transthyretin: developmentally regulated and tissue-specific gene expression.FEBS J. 2009 Oct;276(19):5357-66.

Yaoita Y, Brown DD. (1990). A correlation of thyroid hormone receptor gene expression with amphibian metamorphosis. Genes Dev. 4:1917-1924.

Yen PM. (2001). Physiological and molecular basis of thyroid hormone action. Physiol Rev. 81:1097-1142.

Zoeller RT, Tan SW, Tyl RW. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol. 2007 Jan-Feb;37(1-2):11-53



851: Altered, GABAergic interneurons morphology and function

Short Name: Altered, GABAergic interneurons morphology and function

Biological Organization

Level of Biological Organization
Cellular

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
Caenorhabditis elegans Caenorhabditis elegans Weak NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Strong

GABAergic interneurons play a vital role in the wiring and circuitry of the developing nervous system of all organisms, both invertebrates and vertebrates (Hensch, 2005; Owens and Kriegstein, 2002; Wang et al., 2004). However, restricted expression of GABA in a considerable population of neurons is observed in the non-vertebrate animals. A nematode Caenorhabditis elegans has 302 neurons, among them, 26 cells are GABAergic (Sternberg and Horvitz, 1984; McIntire et al., 1993). Another nematode Ascaris has 26 GABAergic neurons (Obata, 2013). GAD, VGAT, GABA receptors and GABA-system-specific molecules are analogous to those of vertebrates. Except for one interneuron, GABAergic neurons are connected with muscle cells and exert direct inhibitory, sometimes excitatory, control on locomotion, defecation and foraging. The muscle innervation of both excitatory and inhibitory axons is maintained also in Crustacea (Obata, 2013).   


How this Key Event Works

GABAergic interneurons are a heterogeneous group of neuronal cells that consist only 10 to 20% of the total neuronal population (Aika et al., 1994; Halasy and Somogyi, 1993) and they have common features to distinguish them from the pyramidal excitatory cells. These include aspiny dendrites and the release of GABA neurotransmitter, which makes them the main inhibitory source in the central nervous system (CNS) (Markram et al., 2004). A hallmark of interneurons is their structural and functional diversity. Many different subtypes have been identified in the cortex and hippocampus, but a global classification in specific categories is difficult to be established due to the variable morphological and functional properties (Klausberger and Somogyi, 2008; DeFelipe et al., 2013). The interneurons can be primarily identified by their characteristic morphology, which would divide them into 4 basic groups: basket cells, chandelier cells, bouquet cells and bitufted cells. However, a broader classification of these cells would require at least the following criteria: 1) morphology of soma, axonal and dendritic arbors; 2) molecular markers including but not restricted to calcium binding proteins (parvalbumin, calbindin, calretinin) and neuropeptides (e.g., Vasoactive Intestinal Peptide [VIP], reelin, somatostatin); 3) postsynaptic target cells; and 4) functional characteristics (Ascoli et al., 2008). They are neither motor nor sensory neurons, and also differ from projection neurons in that projection neurons send their signals to more distant locations such as the brain or the spinal cord. GABAergic signalling has the unique property of "ionic plasticity", which is dependent on short-term and long-term concentration changes of Cl- and HCO3- in the postsynaptic neurons. The intracellular ion concentrations are largely modified in the course of brain development corresponding to the operation and functional modulation of ion transporters, such as the K-Cl co-transporter 2 (KCC2) and the Na-K-Cl co-transporter 1 (NKCC1) (Blaesse et al., 2009; Blankenship and Feller, 2010). One of the milestones at the crucial stage of brain development is the switch of the GABAergic signalling from depolarizing early in life to a more conventional hyperpolarizing inhibition on maturation (Ben-Ari et al., 2007). This developmental switch is mainly driven by the expression change of the predominant potassium-chloride co-transporters (KCC2 and NKCC1) around this period that results in a shift from high to low intracellular Cl− concentration at the post-synaptic neurons (Lu et al., 1999). GABAergic interneurons are broadly present throughout the CNS, although telencephalic structures, such as the cerebral cortex and hippocampus, show the most abundant quantities of this neurotransmitter (Jones 1987). Complex interconnections between GABAergic interneurons and pyramidal cells shape the responses of pyramidal cells to incoming inputs, prevent runaway excitation, refine cortical receptive fields, and are involved in the timing and synchronisation of network oscillations (Wehr and Zador, 2003; Markram et al., 2004; LeMaqueresse and Monyer, 2013; Hu et al., 2014). GABA is the first excitatory transmitter and is crucial during embryogenesis as it has been shown to affect neurogenesis, differentiation, migration, and integration of developing neurons into neuronal circuits (LoTurco et al., 1995; Heck, et al., 2007). The GABA-mediated depolarizing effects at the post-synaptic neurons in early development are well described (Ben-Ari, 2014) and have been greatly correlated with the emergence of spontaneous network activity, which is the first neuronal activity of the brain (Voigt et al., 2001; Opitz et al., 2002;). This spontaneous network activity is characterized by synchronous bursts of action potentials and concomitant intracellular calcium transients in large group of cells and it has been proposed to have functional relevance during the formation of connections within the network (Wang and Kriegstein, 2010; Ben Ari et al., 2007; Blankenship and Feller, 2010). Furthermore, GABA-mediated depolarisations have recently been shown to promote excitatory synapse formation by facilitating NMDA receptor activation in cortical pyramidal neurons (Wang and Kriegstein, 2008). The effects of depolarizing GABA are also important in the adult brain, as it has impact on synaptic plasticity and is strongly correlated with seizures (Baram and Hatalski, 1998; Ben-Ari et al., 2012). If GABAergic interneuron function breaks down, excitation takes over, leading to seizures and failure of higher brain functions (Westbrook, 2013).


How it is Measured or Detected

Calcium imaging experiments is the most common way to detect the depolarizing action of neurons, as this is correlated with a transient increase in intracellular calcium (Voigt et al., 2001). The local application of GABA agonist, muscimol, during the calcium imaging has been used the last decades in order to investigate the developmental effects of GABA in the post-synaptic neurons (Owens et al., 1996; Gangulu et al., 2001; Baltz et al., 2010; Westerholz et al., 2013). Additionally, GABA-immunohistochemistry can be used for identification and morphometric analysis of the neuronal population (Voigt et al., 2001; De Lima et al., 2007), with the use of anti-GABA antibodies. Protein levels on interneurons can be measured by commercial available antibody sandwich ELISA kits, Western blotting, immunohistochemistry and immunofluorescence and mRNA levels is possible to be measured with RT-PCR, with the use of the primers in interest each time.


References

Aika Y, Ren JQ, Kosaka K, Kosaka T. (1994). Quantitative analysis of GABA-like-immunoreactive and parvalbumin-containing neurons in the CA1 region of the rat hippocampus using a stereological method, the disector. Exp. Brain Res. 99: 267–276.

Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A, Buzsaki G, Cauli B, Defelipe J, Fairen A, et al. (2008). Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 9: 557–568.

Baltz T, deLima AD, Voigt T. (2010). Contribution of GABAergic interneurons to the development of spontaneous activity patterns in cultured neocortical networks. Front. Cell Neurosci. 4:15.

Baram TZ, Hatalski CG. (1998). Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 21: 471–476.

Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R. (2007). GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 87:1215–84.

Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E. (2012). The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18:467–486.

Ben-Ari. (2014). The GABA excitatory/inhibitory developmental sequence: a personal journey. Neuroscience 279:187–219.

Blaesse P, Airaksinen MS, Rivera C, Kaila K. (2009). Cation chloride co-transporters and neuronal function. Neuron 61:820–838.

Blankenship AG, Feller MB. (2010). Mechanisms underlying spon¬taneous patterned activity in develop¬ing neural circuits. Nat. Rev. Neurosci. 11:18–29.

DeFelipe J, López-Cruz PL, Benavides-Piccione R, Bielza C, Larrañaga P, Anderson S et al. (2013). New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci. 14: 202-216.

deLima AD, Lima BD, Voigt T. (2007). Earliest spontaneous activity differentially regulates neocortical GABAergic interneuron subpopulations. Eur.J.Neurosci. 25: 1–16.

Ganguly K, Schinder AF, Wong ST, Poo M. (2001). GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell 105:521–532.

Halasy K, Somogyi P. (1993). Distribution of GABAergic synapses and their targets in the dentate gyrus of rat: A quantitative immunoelectron microscopic analysis. J. Hirnforsch. 34: 299–308.

Heck N, Kilb W, Reiprich P et al. (2007). GABA-A receptors regulate neocortical neuronalmigration in vitro and in vivo. Cereb Cortex. 17:138–148.

Hensch TK. (2005). Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 6: 877-888.

Hu H, Gan J, Jonas P. (2014). Interneurons. Fast-spiking, parvalbumin⁺ GABAergic interneurons: from cellular design to microcircuit function. Science. 345:1255-1263.

Jones EG. (1987). GABA-peptide neurons in primate cerebral cortex. J Mind Behav 8:519–536.

Klausberger T, Somogyi P. (2008). Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science. 321:53–57.

Le Magueresse C, Monyer H. (2013). GABAergic interneurons shape the functional maturation of the cortex. Neuron. 77:388-405.

LoTurco JJ, Owens DF, Heath MJS, Davis MBE, Kriegstein AR. (1995). GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron. 15: 1287–1298.

Lu J, Karadsheh M, Delpire E. (1999). Developmental regulation of the neuronal-specific isoform of K-Cl cotransporter KCC2 in postnatal rat brains. J Neurobiol 39: 558–568.

Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C. (2004). Interneurons of the neocortical inhibitory system. Nature Reviews Neuroscience, 5:793–807.

McIntire SL, Jorgensen E, Kaplan J. and Horvitz, H.R. (1993) The GABAergic nervoussystem of Caenorhabditis elegans. Nature 364, 337–341.

Obata K. (2013).Synaptic inhibition and gamma-aminobutyric acid in the mammalian central nervous system. Proc. Jpn. Acad., Ser. B 89 (2013).

Opitz T, De Lima AD, Voigt T. (2002). Spontaneous development of synchronous oscillatory activity during maturation of cortical networks in vitro. J Neurophysiol 88:2196–2206.

Owens DF, Boyce LH, Davis MBE, Kriegstein AR. (1996). Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci. 16: 6414–6423.

Owens DF, Kriegstein AR. (2002). Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3:715-727.

Sternberg PW. and Horvitz HR. (1984) The genetic control of cell lineage during nematode

development. Annu. Rev. Genet. 18, 489–524.

Voigt T, Opitz T, De Lima AD. (2001). Synchronous oscillatory activity in immature cortical network is driven by GABAergic preplate neurons. J Neurosci 21: 8895–8905.

Wang DD, Kriegstein AR. (2008). GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J Neurosci. 28: 5547–5558.

Wang DD, Kriegstein AR. (2010). Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits. Cereb Cortex 21:574–587.

Wang XJ, Tegner J, Constantinidis C, Goldman-Rakic PS (2004). Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. Proc Natl Acad Sci U S A. 101: 1368-1373.

Wehr M, Zador AM. (2003). Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex. Nature. 426: 442–446.

Westbrook G. (2013). “Seizures and epilepsy” in Principles of Neural Science, E. Kandel, J. H. Schwartz, T. M. Jessell, S. Siegelbaum, A. J. Hudspeth, Eds. McGraw-Hill, New York: 1116–1139.

Westerholz S, de Lima AD, Voigt T. (2013). Thyroid hormone-dependent development of early cortical networks: temporal specificity and the contribution of trkB and mTOR pathways. Front Cell Neurosci 7: 121.


386: Decreased, Neuronal network function in developing brain

Short Name: Decreased, Neuronal network function in developing brain

Biological Organization

Level of Biological Organization
Organ

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
humans Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
mice Mus sp. Strong NCBI
cat Felis catus Strong NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Strong

In vitro studies in brain slices applying electrophysiological techniques showed significant variability among species (immature rats, rabbits and kittens) related to synaptic latency, duration, amplitude and efficacy in spike initiation (reviewed in Erecinska et al., 2004).


How this Key Event Works

Biological state: There are striking differences in neuronal network formation and function among the developing and mature brain. The developing brain shows a slow maturation and a transient passage from spontaneous, long-duration action potentials to synaptically-triggered, short-duration action potentials.

Furthermore, at this precise developmental stage the neuronal network is characterised by "hyperexcitability”, which is related to the increased number of local circuit recurrent excitatory synapses and the lack of γ-amino-butyric acid A (GABAA)-mediated inhibitory function that appears much later. This “hyperexcitability” disappears with maturation when pairing of the pre- and postsynaptic partners occurs and synapses are formed generating population of postsynaptic potentials and population of spikes followed by developmental GABA switch. Glutamatergic neurotransmission is dominant at early stages of development and NMDA receptor-mediated synaptic currents are far more times longer than those in maturation, allowing more calcium to enter the neurons. The processes that are involved in increased calcium influx and the subsequent intracellular events seem to play a critical role in establishment of wiring of neural circuits and strengthening of synaptic connections during development (reviewed in Erecinska et al., 2004). Neurons that do not receive glutaminergic stimulation are undergoing developmental apoptosis.

During the neonatal period, the brain is subject to profound alterations in neuronal circuitry due to high levels of synaptogenesis and gliogenesis. For example, in neuroendocrine regions such as the preoptic area-anterior hypothalamus (POA-AH), the site of gonadotropin-releasing hormone (GnRH) system is developmentally regulated by glutamatergic neurons. The changes in the expression of the N-methyl-D-aspartate (NMDA) receptor subunits NR1 and NR2B system begin early in postnatal development, before the onset of puberty, thereby playing a role in establishing the appropriate environment for the subsequent maturation of GnRH neurons (Adams et al., 1999).

Biological compartments: Neural network formation and function happen in all brain regions but it appears to onset at different time points of development (reviewed in Erecinska et al., 2004). Glutamatergic neurotransmission in hippocampus is poorly developed at birth. Initially, NMDA receptors play important role but the vast majority of these premature glutamatergic synapses are “silent” possibly due to delayed development of hippocampal AMPA receptors. In contrast, in the cerebral cortex the maturation of excitatory glutamatergic neurotransmission happens much earlier. The “silent” synapses disappear by PND 7-8 in both brain regions mentioned above.

There is strong evidence suggesting that NMDA receptor subunit composition controls synaptogenesis and synapse stabilization (Gambrill and Barria, 2011). It is established fact that during early postnatal development in the rat hippocampus, synaptogenesis occurs in parallel with a developmental switch in the subunit composition of NMDA receptors from NR2B to NR2A. It is suggested that early expression of NR2A in organotypic hippocampal slices reduces the number of synapses and the volume and dynamics of spines. In contrast, overexpression of NR2B does not affect the normal number and growth of synapses. However, it does increase spine motility, adding and retracting spines at a higher rate. The C terminus of NR2B, and specifically its ability to bind CaMKII, is sufficient to allow proper synapse formation and maturation. Conversely, the C terminus of NR2A was sufficient to stop the development of synapse number and spine growth. These results indicate that the ratio of synaptic NR2B over NR2A controls spine motility and synaptogenesis, and suggest a structural role for the intracellular C terminus of NR2 in recruiting the signalling and scaffolding molecules necessary for proper synaptogenesis. Interestingly, it was found that genetic deletion of NR3A accelerates glutamatergic synaptic transmission, as measured by AMPAR-mediated postsynaptic currents recorded in hippocampal CA1. Consistent, the deletion of NR3A accelerates the expression of the glutamate receptor subunits NR1, NR2A, and GluR1 sugesting that glutamatergic synapse maturation is critically dependent upon activation of NMDA-type glutamate receptors (Henson et al., 2012).

General role in biology: The development of neuronal networks can be distinguished into two phases: an early ‘establishment’ phase of neuronal connections, where activity-dependent and independent mechanisms could operate, and a later ‘maintenance’ phase, which appears to be controlled by neuronal activity (Yuste and Sur, 1999). These neuronal networks facilitate information flow that is necessary to produce complex behaviors, including learning and memory (Mayford et al., 2012).


How it is Measured or Detected

Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?

In vivo: The recording of brain activity by using electroencephalography (EEG), electrocorticography (ECoG) and local field potentials (LFP) assists towards the collection of signals generated by multiple neuronal cell networks. Advances in computer technology have allowed quantification of the EEG and expansion of quantitative EEG (qEEG) analysis providing a sensitive tool for time-course studies of different compounds acting on neuronal networks' function (Binienda et al., 2011). The number of excitatory or inhibitory synapses can be functionally studied at an electrophysiological level by examining the contribution of glutamatergic and GABAergic synaptic inputs. The number of them can be determined by variably clamping the membrane potential and recording excitatory and inhibitory postsynaptic currents (EPSCs or IPSCs) (Liu, 2004).

In vitro: Microelectrode array (MEA) recordings are also used to measure electrical activity in cultured neurons (Keefer et al., 2001, Gramowski et al., 2000; Gopal, 2003; Johnstone et al., 2010). MEAs can be applied in high throughput platforms to facilitate screening of numerous chemical compounds (McConnell et al., 2012). Using selective agonists and antagonists of different classes of receptors their response can be evaluated in a quantitative manner (Novellino et al., 2011; Hogberg et al., 2011). Patch clamping technique can also be used to measure neuronal network activity.


References

Adams MM, Flagg RA, Gore AC., Perinatal changes in hypothalamic N-methyl-D-aspartate receptors and their relationship to gonadotropin-releasing hormone neurons. Endocrinology. 1999 May;140(5):2288-96.

Binienda ZK, Beaudoin MA, Thorn BT, Ali SF. (2011) Analysis of electrical brain waves in neurotoxicology: γ-hydroxybutyrate. Curr Neuropharmacol. 9: 236-239.

Erecinska M, Cherian S, Silver IA. (2004) Energy metabolism in mammalian brain during development. Prog Neurobiol. 73: 397-445.

Gambrill AC, Barria A. NMDA receptor subunit composition controls synaptogenesis and synapse stabilization. Proc Natl Acad Sci U S A. 2011:108(14):5855-60.

Gopal K. (2003) Neurotoxic effects of mercury on auditory cortex networks growing on microelectrode arrays: a preliminary analysis. Neurotoxicol Teratol. 25: 69-76.

Gramowski A, Schiffmann D, Gross GW. (2000) Quantification of acute neurotoxic effects of trimethyltin using neuronal networks cultures on microelectrode arrays. Neurotoxicology 21: 331-342.

Henson MA, Larsen RS, Lawson SN, Pérez-Otaño I, Nakanishi N, Lipton SA, Philpot BD. (2012) Genetic deletion of NR3A accelerates glutamatergic synapse maturation. PLoS One. 7(8).

Hogberg HT, Sobanski T, Novellino A, Whelan M, Weiss DG, Bal-Price AK. (2011) Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons. Neurotoxicology 32: 158-168.

Johnstone AFM, Gross GW, Weiss D, Schroeder O, Shafer TJ. (2010) Use of microelectrode arrays for neurotoxicity testing in the 21st century Neurotoxicology 31: 331-350.

Keefer E, Norton S, Boyle N, Talesa V, Gross G. (2001) Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays. Neurotoxicology 22: 3-12.

Liu G. (2004) Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites. Nat Neurosci. 7: 373-379.

Mayford M, Siegelbaum SA, Kandel ER. (2012) Synapses and memory storage. Cold Spring Harb Perspect Biol. 4. pii: a005751.

McConnell ER, McClain MA, Ross J, LeFew WR, Shafer TJ. (2012) Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set. Neurotoxicology 33: 1048-1057.

Novellino A, Scelfo B, Palosaari T, Price A, Sobanski T, Shafer TJ, Johnstone AF, Gross GW, Gramowski A, Schroeder O, Jügelt K, Chiappalone M, Benfenati F, Martinoia S, Tedesco MT, Defranchi E, D'Angelo P, Whelan M. (2011) Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals. Front Neuroeng. 4: 4.

Yuste R, Peinado A, Katz LC. (1992) Neuronal domains in developing neocortex. Science 257: 665-669.


277: Decreased, Thyroid hormone synthesis

Short Name: Decreased, Thyroid hormone synthesis

AOPs Including This Key Event


Biological Organization

Level of Biological Organization
Molecular

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
rat Rattus norvegicus Strong NCBI
human Homo sapiens Strong NCBI
Pig Pig Strong NCBI
Xenopus laevis Xenopus laevis Moderate NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Strong

Decreased TH synthesis resulting from TPO or NIS inhibition is conserved across taxa, with in vivo evidence from humans, rats, amphibians, and birds, and in vitro evidence from rat and porcine microsomes. Indeed, TPO and NIS mutations result in congenital hypothyroidism in humans (Bakker et al., 2000; Spitzweg and Morris, 2010), demonstrating the essentiality of TPO and NIS function toward maintaining euthyroid status.

Typically decreased serum thyroxine (T4) is used as a surrogate measure to indicate chemical-mediated decreases in TH synthesis. However, clinical and veterinary management of hyperthyroidism and Grave's disease involves administration of drugs including propylthiouracil and methimazole, known to decrease TH synthesis, indicating strong medical evidence for chemical initiation of this event (Zoeller and Crofton, 2005).


How this Key Event Works

Thyroid hormone (TH) synthesis is regulated by thyroid-stimulating hormone (TSH) binding to its receptor and thyroidal availability of iodine via the sodium iodide symporter (NIS). Other proteins contributing to TH production in the thyroid gland, including thyroperoxidase (TPO), dual oxidase enzymes (DUOX), and pendrin are also necessary for iodothyronine production (Zoeller et al., 2007). The production of THs in the thyroid gland and serum levels are controlled by an efficiently regulated feedback mechanism: the hypothalamus-pituitary-thyroid (HPT) axis. This regulatory system includes: 1) the hypothalamic secretion of the thyrotropin-releasing hormone (TRH); 2) the thyroid-stimulating hormone (TSH) secretion from the anterior pituitary; 3) hormonal transport by the plasma binding proteins; 4) cellular uptake mechanisms at the cell level; 5) intracellular control of TH concentration by deiodinating mechanisms; 6) transcriptional function of the nuclear TH receptor; and 7) in the fetus, the transplacental passage of T4 and T3 (Zoeller et al., 2007).

TRH and the TSH primarily regulate the production of pro-hormone T4, and to a lesser extent of T3, the biologically active TH. Most of the hormone released into circulation is is in the form of T4, while peripheral deiodination of T4 is responsible for the majority of circulating T3. Outer ring deiodination of T4 is conducted by activation of the deiodinating enzymes D1 and D2 (Bianco et al., 2006), takes place mainly in liver and kidney, but also in other target organs such as in the brain, the anterior pituitary, brown adipose tissue, thyroid and skeletal muscle (Gereben et al., 2008; Larsen, 2009).

The majority of evidence for the ontogeny of TH synthesis comes from measurements of serum hormone concentrations. And, importantly, the impact of xenobiotics on fetal hormones must include the influence of the maternal compartment since a majority of fetal THs are derived from maternal blood, especially early in fetal life. In humans, THs can be found in the fetus as early as gestational weeks 10-12, and concentations rise continuously until birth. At term fetal T4 is similar to maternal levels, but T3 remains 2-3 fold lower than maternal levels. In rats, THs can be detected in the fetus as early as the second gestational week, but fetal synthesis does not start until around the third week of gestation. (see Howdeshell, 2002; Santisteban and Bernal, 2005 for review).

Decreased TH synthesis in the thyroid gland may result from one or a combination of a set of possible molecular-initiating events (MIEs) including: 1) Inhibition of TPO, inhibition of the NIS, or dietary iodine insufficiency. Theoretically, decreased synthesis of Tg could also affect TH production (Kessler et al., 2008; Yi et al., 1997). 2) Decreased TH synthesis in cases of clinical hypothyroidism may be due to Hashimoto's thyroiditis or other forms of thyroiditis, or physical destruction of the thyroid gland as in radioablation or surgical treatment of thyroid lymphoma. 3) It is possible that TH synthesis may also be reduced subsequent to disruption of the negative feedback mechanism governing TH homeostasis, e.g. pituitary gland dysfunction may result in a decreased TSH signal with concomitant T3 and T4 decreases. 4) More rarely, hypothalamic dysfunction can result in decreased TH synthesis.

It should be noted that different species and different lifestages store different amounts of TH precursor and iodine within the thyroid gland. Thus, decreased TH synthesis via transient iodine insufficiency or inhibition of TPO may not affect TH release from the thyroid gland until depletion of stored iodinated Tg. Adult humans may store Tg-DIT residues to supply for several months to a year of TH demand (Greer et al., 2002). Neonates and infants have a much more limited supply of less than a week.


How it is Measured or Detected

Decreased TH synthesis is often implied by measurement of TPO and NIS inhibition measured clinically and in laboratory models asthese enzymes are essential for TH synthesis. Rarely is decreased TH synthesis measured directly, but rather the impact of chemicals onthe quantity of T4 released from the thyroid gland is assessed (e.g., Romaldini et al., 1988). Methods used include, use of radiolabel tracer compounds, radioimmunoassay, ELISA, and analytical detection.

Recently, amphibian thyroid explant cultures have been used to demonstrate direct effects of chemicals on TH synthesis, as this model contains all of the necessary synthesis enzymes including TPO and NIS (Hornung et al., 2010). For this work TH was measured by HPLC/ICP-mass spectometry. Decreased TH synthesis and release, using T4 release as the endpoint, has been shown for thiouracil antihyperthyroidism drugs including MMI, PTU, and the NIS inhibitor perchlorate (Hornung et al., 2010).


References

Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ. 2000. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). The Journal of clinical endocrinology and metabolism. Oct;85:3708-3712.

Bianco AC, Kim BW. (2006). Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 116: 2571–2579.

Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeöld A, Bianco AC. (2008). Cellular and molecular basis of deiodinase-regulated thyroid hormone signalling. Endocr Rev. 29:898–938.

Greer MA, Goodman G, Pleus RC, Greer SE. 2002. Health effects assessment for environmental perchlorate contamination: the dose response for inhibition of thyroidal radioiodine uptake in humans. Environmental health perspectives. Sep;110:927-937.

Howdeshell KL. 2002. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect. 110 Suppl 3:337-48.

Hornung MW, Degitz SJ, Korte LM, Olson JM, Kosian PA, Linnum AL, Tietge JE. 2010. Inhibition of thyroid hormone release from cultured amphibian thyroid glands by methimazole, 6-propylthiouracil, and perchlorate. Toxicological Sciences Nov;118:42-51.

Kessler J, Obinger C, Eales G. Factors influencing the study of peroxidase-generated iodine species and implications for thyroglobulin synthesis. Thyroid. 2008 Jul;18(7):769-74. doi: 10.1089/thy.2007.0310

Larsen PR. (2009).Type 2 iodothyronine deiodinase in human skeletal muscle: new insights into its physiological role and regulation. J Clin Endocrinol Metab. 94:1893-1895.

Romaldini JH, Farah CS, Werner RS, Dall'Antonia Júnior RP, Camargo RS. 1988. "In vitro" study on release of cyclic AMP and thyroid hormone in autonomously functioning thyroid nodules. Horm Metab Res.20:510-2.

Santisteban P, Bernal J. Thyroid development and effect on the nervous system. Rev Endocr Metab Disord. 2005 Aug;6(3):217-28.

Spitzweg C, Morris JC. 2010. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Molecular and cellular endocrinology. Jun 30;322:56-63.

Yi X, Yamamoto K, Shu L, Katoh R, Kawaoi A. Effects of Propylthiouracil (PTU) Administration on the Synthesis and Secretion of Thyroglobulin in the Rat Thyroid Gland: A Quantitative Immuno-electron Microscopic Study Using Immunogold Technique. Endocr Pathol. 1997 Winter;8(4):315-325.

Zoeller RT, Crofton KM. 2005 Mode of action: developmental thyroid hormone insufficiency--neurological abnormalities resulting from exposure to propylthiouracil. Crit Rev Toxicol. 35:771-81

Zoeller RT, Tan SW, Tyl RW. 2007. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical reviews in toxicology. Jan-Feb;37:11-53.



Adverse Outcomes

Title Short name
Impairment, Learning and memory Impairment, Learning and memory

341: Impairment, Learning and memory

Short Name: Impairment, Learning and memory

AOPs Including This Key Event

AOP ID and Name Event Type
13: Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities AdverseOutcome
48: Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment. AdverseOutcome
54: Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children AdverseOutcome
77: Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 1 KeyEvent
78: Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure 1 KeyEvent
87: Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2 KeyEvent
88: Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 3 KeyEvent
89: Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 4 KeyEvent
90: Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure 2 KeyEvent
12: Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging AdverseOutcome

Biological Organization

Level of Biological Organization
Individual

Evidence Supporting Applicability of this Event


Taxonomic Applicability
Term Scientific Term Evidence Links
human Homo sapiens Strong NCBI
rat Rattus norvegicus Strong NCBI
fruit fly Drosophila melanogaster Strong NCBI
zebrafish Danio rerio Strong NCBI
gastropods Physa heterostropha Strong NCBI
Life Stage Applicability
Life Stage Evidence
During brain development Strong
Sex Applicability
Sex Evidence
Mixed Strong

Learning and memory have been studied in invertebrates such as gastropod molluscs and drosophila and vertebrates such as rodents and primates. Recently, larval zebrafish has also been suggested as a model for the study of learning and memory (Roberts et al., 2013).


How this Key Event Works

Learning can be defined as the process by which new information is acquired to establish knowledge by systematic study or by trial and error (Ono, 2009). Two types of learning are considered in neurobehavioral studies: a) associative learning and b) non-associative learning.

Associative learning is learning by making associations between different events. In associative learning, a subject learns the relationship among two different stimuli or between the stimulus and the subject’s behaviour. Classical conditioning, operant conditioning and category learning are some examples of associative learning. On the other hand, non-associative learning can be defined as an alteration in the behavioral response that occurs over time in response to a single type of stimulus. Habituation and sensitization are some examples of non-associative learning. Another important type of learning is emotional learning and the simplest form of emotional regulation is extinction (Quirk and Mueller, 2008). During extinction, conditioned response to a stimulus decreases when the reinforcer is omitted and fear conditioning experiments help to elucidate the underlined mechanism.

The memory to be formed requires acquisition, retention and retrieval of information in the brain, which is characterised by the non-conscious recall of information (Ono, 2009). Memory is considered very important as it allows the subjects to access the past, to form experience and consequently to acquire skills for surviving purposes. There are three main categories of memory, including sensory memory, short-term or working memory (up to a few hours) and long-term memory (up to several days or even much longer). At the cellular level the storage of long-term memory is associated with increased gene expression and protein synthesis as well as formation of novel synaptic connections (Lynch, 2004).

Learning-related processes require neural networks to detect correlations between events in the environment and store these as changes in synaptic strength (Abbott and Nelson, 2000). Long-term potentiation (LTP) and long-term depression (LTD) are two fundamental processes involved in cognitive functions (Abbott and Nelson, 2000; Malenka and Bear, 2004), which respectively, strengthen synaptic inputs that are effective at depolarizing the postsynaptic neuron and weaken inputs that are not, thus reinforcing useful pathways in the brain. Synapses that are strengthened become more effective at depolarizing the postsynaptic neuron, eventually driving neuronal activity to saturation (Abbott and Nelson, 2000). As correlated activity of presynaptic and postsynaptic neurons drives strengthening of specific synapses, the postsynaptic neuron will be driven more strongly, and so presynaptic inputs that were initially only poorly correlated with postsynaptic firing will be better able to trigger firing of the postsynaptic neuron. This implies that nervous systems must have a matching set of plasticity mechanisms that counteract these destabilizing forces. The cortical and hippocampal pyramidal neurons have a target firing rate, and synaptic strengths are regulated to maintain these rates relatively constant in the face of perturbations in input channel (Burrone et al., 2002). This provides a robust mechanism for generating stability in network function in the face of learning-related changes in synaptic input. In principle, neurons could maintain stable firing rates through homeostatic regulation of many aspects of neuronal excitability. These possibilities include balancing inward and outward voltage-dependent conductances that determine firing properties generally called “intrinsic excitability” (Marder and Goaillard, 2006; Zhang and Linden 2003), regulating inhibitory and/or excitatory synaptic strength (Turrigiano, 2011) or synapse number (Kirov et al., 1999) or by adjusting the ease with which other forms of plasticity can be induced, so-called “metaplasticity” (Abraham and Bear, 1996). Evidence suggests that all of these mechanisms can contribute to the homeostatic regulation of neuronal firing rates in central circuits. Activity-dependent alteration in synaptic strength is a fundamental property of the vertebrate central nervous system and is thought to underlie learning and memory.

A major expression mechanism of synaptic scaling is changes in the accumulation of synaptic glutamate receptors. Central synapses typically cluster both AMPA receptors and NMDA receptors. AMPA receptors are ionotropic and carry out the majority of excitatory synaptic current in the central nervous system; NMDA receptors are also ionotropic but open as a function of voltage, flux calcium, and mediate a number of calcium-dependent forms of synaptic plasticity (Malenka and Bear, 2004). Synaptic scaling results in postsynaptic changes in both types of glutamate receptors (Stellwagen and Malenka, 2006; Watt et al., 2000) and can therefore be monitored by measuring changes in receptor accumulation at synapses.

The best characterized form of LTP occurs in the CA1 region of the hippocampus, in which LTP is initiated by transient activation of receptors and is expressed as a persistent increase in synaptic transmission through AMPA receptors followed by activation of NMDARs. This increase is due, at least in part, to a postsynaptic modification of AMPA-receptor function; this modification could be caused by an increase in the number of receptors, their open probability, their kinetics or their single-channel conductance. Summing up activity-dependent alteration in synaptic strength is a fundamental property of the vertebrate central nervous system that underlies learning and memory processes.

It is appropriate to state that while much emphasis has been given on the key role of the hippocampus in memory, it would probably be simplistic to attribute memory deficits solely to hippocampal damage (Barker and Warburton, 2011). There is substantial evidence that fundamental memory functions are not mediated by hippocampus alone but require a network that includes, in addition to the hippocampus, anterior thalamic nuclei, mammillary bodies cortex, cerebellum and basal ganglia (Aggleton and Brown, 1999; Doya, 2000; Mitchell et al., 2002, Toscano and Guilarte, 2005). Each of these brain structures can be potentially damaged leading to more or less severe impairment of learning and memory.

Amnesia is defined as the impairment or loss of memory. Depending on the cause amnesia can be characterised as functional, organic amnesia or infantile amnesia. Dementia, is a brain disease that causes a long term and often gradual decrease in the ability to think and remember as well as problems with language, and a decrease in motivation (Solomon and Budson, 2011). It is an intellectual impairment observed mainly in elderly people due to the progress of a neudegenerative disease. In younger people this type of impairment is known as presenile dementia. The most common affected areas include memory, visual-spatial, language, attention, and executive function (problem solving). Therefore, very often, short-time memory, mind, speech and motor skills are affected. Certain forms of dementia can be treated, to some extent. The most common form of dementia is Alzheimer's disease, which accounts for between 50 and 60 percent of all cases. Other types include vascular dementia and Lewy body dementia (Burns, 2009). Initial symptoms in Alzheimer's disease is memory impairment (for review, Arhavsky, 2010), in particular short-term/episodic memory, which depends largely on hippocampal system (for review, Storandt et al., 2009; Daulatzai, 2013). This pathological and age-related memory decline is believed to be a result of reduced synaptic plasticity, including changes in the NR2 subunit composition of the NMDA receptor (for review, Wang et al., 2014). It can then evolve towards a global loss of cognitive functions defined as dementia (for review, Larson et al., 1992).

In the past, the study of infant memory has relied in models and tests used in adults and more specific amnesic patients with hippocampal damage. For this reason, the infant memory has been distinguished to declarative or explicit memory and nondeclarative or implicit memory. However, in recent years this distinction such as explicit/implicit are no longer accepted especially in relation to hippocampal function as new theories have been emerged (reviewed in Mullally and Maguire, 2014). Furthermore, there are findings that even very young infants have a more adept and flexible memory system than was previously thought and neurobiological data derived from non-humans provide support to the new hypotheses about hippocampal development that would facilitate to interpret infant memory data from humans.


How it is Measured or Detected

In humans: The neuropsychological tests have been used for neurosensory assessment of humans including identification of altered neurobehaviours in vulnerable populations such as children (Rohlman et al., 2008). Intelligence tests, perceptual motor tests, planning tests, and logical, spatial, short term, long term, and working memory tasks can be used in neurobehavioral studies to assess learning and memory. The same test is also used to identify risks from occupational exposure to chemicals.

In laboratory animals: Current behavioural tests used for evaluating learning and memory processes in rats such as the Morris water maze, Radial maze, Passive avoidance and Spontaneous alternation are characterized in the KE Decreased Neuronal Network Function.

Cognitive function including learning and memory is an important endpoint required by the US EPA and OECD Developmental Neurotoxicity (DNT) Guidelines (OCSPP 870.6300 or OECD 426). The methods applied to assess learning and memory have been reviewed (Markis et al., 2009) and discussed in the OECD Series on testing and assessment number 20, Guidance document for Neurotoxicity Testing (2004) . This document is considered an essential supplement to a substantial number of already existing OECD Test Guidelines relevant for neurotoxicity testing.


Regulatory Examples Using This Adverse Outcome

Impairment of learning and memory is considered a chemically-induced adverse outcome that is used for risk assessment and management purposes. Neurotoxicity testing guidelines (OECD TG 424 and 426) are implemented on a number of occasions where the neurotoxic properties of a compound have to be assessed in order to comply with relevant EU regulations. These regulations are as follows: REACH regulation (EC, No 1907/2006), Plant protection products regulation (EC, No 1107/2009), Biocidal products regulation (EC, No 528/2012), Test methods regulation (EC, No 440/2008), Classification, labelling and packaging of substances and mixtures (EC, No 1272/2008) and Maximum residue levels of pesticides in or on food and feed of plant and animal origin regulation (EC, No 396/2005).

The US EPA and OECD Developmental Neurotoxicity (DNT) Guidelines (OCSPP 870.6300 or OECD 426) both require testing of learning and memory. These DNT Guidelines have been used to identify developmental neurotoxicity and adverse neurodevelopmental outcomes (Makris et al., 2009). Also in the frame of the OECD GD 43 (2008) on reproductive toxicity, learning and memory testing may have potential to be applied in the context of developmental neurotoxicity studies. However, many of the learning and memory tasks used in guideline studies may not readily detect subtle impairments in cognitive function associated with modest degrees of developmental thyroid disruption (Gilbert et al., 2012).


References


Abbott LF, Nelson SB. (2000) Synaptic plasticity: Taming the beast. Nat Neurosci 3: 1178–1183.

Abraham HAJ, Bear MF. Bidirectional modification of CA1 synapses in the adult hippocampus in vivo. Nature. 1996 May 9;381(6578):163-6.

Aggleton JP, Brown MW. (1999) Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci. 22: 425-489.

Arshavsky YI. 2010. Why Alzheimer's disease starts with a memory impairment: neurophysiological insight. J Alzheimers Dis 20(1): 5-16.

Barker GR, Warburton EC. (2011) When is the hippocampus involved in recognition memory? J Neurosci. 31: 10721-10731.

Burns A, Iliffe, S. (2009). Dementia. BMJ (Clinical research ed.) 338: b75.

Burrone J, O’Byrne M, Murthy VN. (2002) Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons. Nature 420: 414–418.

Daulatzai MA. 2013. Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease. Neurotox Res 24(3): 407-459.

Doya K. (2000) Complementary roles of basal ganglia and cerebellum in learning and motor control. Curr Opin Neurobiol. 10: 732-739.

Gilbert ME, Rovet J, Chen Z, Koibuchi N. (2012) Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology 33: 842-52.

Kirov SA, Sorra KE, Harris KM. (1999) Slices have more synapses than perfusion-fixed hippocampus from both young and mature rats. J Neurosci. 19: 2876–2886.

Larson EB, Kukull WA, Katzman RL. 1992. Cognitive impairment: dementia and Alzheimer's disease. Annual review of public health 13: 431-449.

Lynch MA. (2004) Long-term potentiation and memory. Physiol Rev. 84: 87-136.

Makris SL, Raffaele K, Allen S, Bowers WJ, Hass U, Alleva E, Calamandrei G, Sheets L, Amcoff P, Delrue N, Crofton KM. (2009) A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect. 117:17-25.

Malenka RC, Bear MF (2004). LTP and LTD: An embarrassment of riches. Neuron 44: 5–21.

Marder E, Goaillard JM. (2006). Variability, compensation and homeostasis in neuron and network function. Nat Rev Neurosci. 7: 563–574.

Mitchell AS, Dalrymple-Alford JC, Christie MA. (2002) Spatial working memory and the brainstem cholinergic innervation to the anterior thalamus. J Neurosci. 22: 1922-1928.

Mullally SL, Maguire EA. (2014) Learning to remember: the early ontogeny of episodic memory. Dev Cogn Neurosci. 9: 12-29.

OECD (2004) Series on testing and assessment number 20, Guidance document for neurotoxicity testing.

OECD (2007). Test Guideline 426. OECD Guideline for Testing of Chemicals. Developmental Neurotoxicity Study. http://www.oecd.org/document/55/0,3343,en_2649_34377_2349687_1_1_ 1_1,00.html

OECD (2008) Nr 43 GUIDANCE DOCUMENT ON MAMMALIAN REPRODUCTIVE TOXICITY TESTING AND ASSESSMENT. ENV/JM/MONO(2008)16

Ono T. (2009) Learning and Memory. Encyclopedia of neuroscience. M D. Binder, N. Hirokawa and U. Windhorst (Eds). Springer-Verlag GmbH Berlin Heidelberg. pp 2129-2137.

Quirk GJ, Mueller D. (2008) Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33: 56-72.

Roberts AC, Bill BR, Glanzman DL. (2013) Learning and memory in zebrafish larvae. Front Neural Circuits 7: 126.

Rohlman DS, Lucchini R, Anger WK, Bellinger DC, van Thriel C. (2008) Neurobehavioral testing in human risk assessment. Neurotoxicology. 29: 556-567.

Solomon, Andrew E. Budson, Paul R. (2011). Memory loss : a practical guide for clinicians. Elsevier Saunders. ISBN 9781416035978

Stellwagen D, Malenka RC. (2006) Synaptic scaling mediated by glial TNF-α. Nature 440: 1054–1059.

Storandt M, Mintun MA, Head D, Morris JC. 2009. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol 66(12): 1476-1481.

Toscano CD, Guilarte TR. (2005) Lead neurotoxicity: From exposure to molecular effects. Brain Res Rev. 49: 529-554.

Turrigiano G. (2011) Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu Rev Neurosci. 34: 89–103.

Wang D, Jacobs SA, Tsien JZ. 2014. Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline. Expert opinion on therapeutic targets 18(10): 1121-1130.

Watt AJ, van Rossum MC, MacLeod KM, Nelson SB, Turrigiano GG. (2000) Activity coregulates quantal AMPA and NMDA currents at neocortical synapses. Neuron 26: 659–670.

Zhang W, Linden DJ. (2003) The other side of the engram: Experience-driven changes in neuronal intrinsic excitability. Nat Rev Neurosci. 4: 885–900.


Scientific evidence supporting the linkages in the AOP

Upstream Event Relationship Type Downstream Event Evidence Quantitative Understanding
Reduced, Release of BDNF indirectly leads to Decreased, Synaptogenesis Moderate Weak
Reduced, Release of BDNF indirectly leads to Altered, GABAergic interneurons morphology and function Moderate Weak
Altered, GABAergic interneurons morphology and function directly leads to Decreased, Synaptogenesis Strong Weak
Decreased, Synaptogenesis directly leads to Decreased, Neuronal network function in developing brain Weak Weak
Decreased, Neuronal network function in developing brain directly leads to Impairment, Learning and memory Strong Weak
Decreased, Thyroxine (T4) in neuronal tissue directly leads to Reduced, Release of BDNF Weak Weak
Inhibition, Na+/I- symporter (NIS) directly leads to Decreased, Thyroidal iodide uptake Strong Strong
Decreased, Thyroxin (T4) in serum directly leads to Decreased, Thyroxine (T4) in neuronal tissue Strong Weak
Decreased, Thyroidal iodide uptake directly leads to Decreased, Thyroid hormone synthesis Strong Strong
Decreased, Thyroid hormone synthesis directly leads to Decreased, Thyroxin (T4) in serum Strong Strong

Graphical Representation

Overall Assessment of the AOP

This AOP refers mainly to humans and rodent species (principally rat) with regard to taxa. All the KEs are applicable to either sex ("mixed", as indicated under description of individual KEs and KERs), and the life-stage, for all the KEs, is defined as "during brain development", encompassing foetal and perinatal stage, continuing also during childhood and youth.

Biological Plausibility: The functional relationship between NIS and thyroidal iodide uptake is well established. In the human, NIS mutations are associated with congenital iodide transport defect, a condition characterized by low iodide uptake, hypothyroidism and goiter (Bizhanova and Kopp, 2009; De La Vieja et al., 2000; Pohlenz and Refetoff, 1999). The same is true for the relationship between iodide uptake and serum TH concentration, as it is known that Iodide Deficient (ID) suffer also by low thyroid levels in the blood (Wolff, 1998; DeLange, 2000). The correlation of serum and brain concentrations of TH are supported by a smaller amount of quantitative data but the biological plausibility of this connection is mainly based on the number of studies that show that the brain TH is proportional to the serum TH (Broedel et al., 2003). BDNF is thought to underlie the effects of developmental hypothyroidism but this notion is based mainly on their common physiological role during brain development rather than on solid experimental evidence (Gilbert and Lasley, 2013). On the other hand, the role of BDNF on the GABAergic interneurons development and function is well established, as many experimental data have been produced the last decades in support to this relationship (Woo and Lu, 2006; Palizvan et al., 2004; Patz et al., 2004). It is also widely accepted that the GABAergic signalling and therefore the proper function of GABAergic interneurons is fundamental for the normal synapse formation, which in turn controls the neuronal network formation, maturation and function. Numerous studies have shown that the depolarizing GABA signalling is controlled by the intracellular Cl- concentration in the postsynaptic cells and is the first drive for synapse formation (Wang and Kriegstein, 2008; Cancedda et al., 2007; Ge et al., 2006; Chudotvorova et al., 2005; Akerman and Cline, 2006). This early synaptogenesis period is critical for the establishment of the basic neuronal circuitry, despite the fact that synaptogenesis is a continuous process throughout life (Rodier, 1995).

Dose-response concordance: Multiple events were considered together in only limited number of studies. There is overwhelming evidence that supports the concordance of NIS inhibition with the decrease of thyroidal iodide uptake or the lower levels of serum TH but these two events have rarely been tested together. However, in the few cases that the levels of thyroidal iodide and the serum TH levels are measured in the same study the results are mostly conflicting, mainly due to the well-developed compensatory mechanisms that exist to maintain the TH levels in the body. That means that the effects of NIS inhibitors might not be detectable in short-term or low-dose experiments. Perchlorate is a well-described NIS inhibitor and the interpretation of related studies is straightforward because thyroid is considered the critical effect organ of perchlorate toxicity (National Research Council 2005); thus, any effects of perchlorate on the nervous system are necessarily interpreted to be subsequent to inhibition of iodide uptake by the thyroid gland and to a reduction in serum THs. Indeed, the use of potassium or sodium perchlorate has contributed to the identification of a dose-response relationships between NIS inhibition and thyroidal iodide uptake (Greer et al., 2002; Tonacchera et al., 2004; Cianchetta et al., 2010; Waltz et al., 2010; Lecat-Guillet et al., 2007; 2008) but the respective concordance with serum TH was not shown in most of these studies. On the other hand, in the human and animal studies that revealed a strong dose-dependent association between perchlorate exposure and circulating levels of TH (Blount et al., 2006; Cao et al., 2010; Suh et al., 2013; Steinmaus et al., 2007; Steinmaus et al., 2013; Siglin et al., 2000; Caldwell et al., 1995; Argus research laboratories 2001; York et al., 2003; York et al., 2004), the decrease of thyroidal iodide was not investigated. The downstream effects of TH insufficiency are better understood and documented but the majority of the dose-response data are derived from hypothyroid rodents after exposure with propylthiouracil (PTU) and methimazole (MMI), which is the most common used chemicals for the production of hypothyroid state to animals. Those types of experiments give information on the mechanisms through which TH insufficiency leads to neurodevelopmental deficits, but this pathway cannot be connected with NIS inhibition as data on specific NIS inhibitors is still lacking. In regards to the downstream events in the pathway, there is a strong correlation between each KE but the majority of the studies have been performed under severe hypothyroid conditions (high doses of PTU and/or MMI, thyroidectomies); therefore it is difficult to establish the dose-response relationships in each one of them. The association between serum TH levels and BDNF protein in the brain is very well documented but with the exception of few cases (Chakraborty et al., 2012; Blanco et al., 2013) no dose-response experiments are available. The same problem is also encountered in the relationship between BDNF levels and the GABAergic function, as there is only one recent study (Westerholz et al., 2013) that describes a correlation between these two events, but the results are described on the basis of T3 presence or complete absence in the cultures, which does not allow the establishment of dose-response evaluation. However, a dose-response relationship has been shown in earlier studies between the T3 hormone and the density of synapses in cortical cultures, an effect which was paralleled with the electrical activity of the network (Westerholz et al., 2010; Hosoda et al., 2003). More recently, a model of low level TH disruption has been developed, in which different concentrations of PTU have been tested and the subsequent dose-response relationships with GABAergic interneurons expression, synaptogenesis and learning and memory deficits were established (Sui and Gilbert, 2003; Gilbert and Sui, 2006; Gilbert, 2011; Gilbert et al, 2006; Berbel et al., 1996). Additionally, results from animal studies with perchlorate have also shown a dose-dependent reduction in excitatory and inhibitory synaptic function leading to learning and memory impairments (Gilbert and Sui, 2008). In contrast, there is only limited data in support to the correlation between TH insufficiency and the neuronal network function, and no dose-response relationship can be established.

Temporal concordance: In regards to temporality, the concordance between the KEs from the NIS inhibition until the TH levels in the brain is well-established. It is widely accepted that the most important role of iodine is the formation of the thyroid hormones (T4 and T3) and that iodine deficiency early in development can cause severe hypothyroidism leading to irreversible neurocognitive impairments (DeLange, 2000; Zimmermann et al., 2006). The majority of the data on TH insufficiency is derived from studies performed in different developmental stages and this study design facilitates the establishment of temporal concordance between the downstream KEs in the AOP. In general, TH insufficiency during the prenatal and early post-natal period is correlated with deficits in GABAergic morphology and function, especially of PV-positive interneurons (Berbel et al., 1996; Gilbert et al., 2007; Westerholz et al., 2010; 2013), with the decrease of active synapses and of synchronized electrical activity in cortical networks (Westerholz et al., 2010; Hosoda et al., 2003). This developmental window is known to be critical for the brain development and therefore TH deficits during this period has been correlated with mental retardation and other neurological impairments in children, which in some cases are irreversible (Mirabella et al., 2000; Porterfield and Hendrich, 1993). In at least two studies multiple KEs have been considered together and provide important information on the temporality of the AOP. Westerholz et al., 2010 and 2013 have shown that TH insufficiency during the first two postnatal weeks may cause alterations in the morphology and function of PV-positive GABAergic interneurons, with subsequent effects on the number of active synapses and the electrical activity of the neuronal network. During the same period the inhibition of BDNF function was shown to be also involved in the formation of synaptic connections (Westerholz et al., 2013). Further investigation of the mediating mechanisms revealed that a critical function in the above mentioned cascade was the timely shift of GABA signalling from depolarization to hyperpolarization, a milestone in brain development. The GABA switch takes place at the end of the second postnatal week in rodents, and thus we can conclude that all the KEs are performed during the perinatal period up to 14 days postnatal, which fits in the overall AOP, as this is the critical period for synaptogenesis and subsequently for the proper development of learning and memory functions.


Domain of Applicability

Life Stage Applicability
Life Stage Evidence
Foetal Strong
Perinatal Strong
During brain development Strong
Taxonomic Applicability
Term Scientific Term Evidence Links
Homo sapiens Homo sapiens Strong NCBI
Rattus sp. Rattus sp. Strong NCBI
Sex Applicability
Sex Evidence
Male Strong
Female Strong

This AOP refers mainly to humans and rodent species (principally rat) with regard to taxa. All the KEs are applicable to either sex ("mixed", as indicated under description of individual KEs and KERs), and the life-stage, for all the KEs, is defined as "during brain development", encompassing foetal and perinatal stage, continuing also during childhood and youth.

Essentiality of the Key Events

The essentiality of each one of the key events in this AOP was supported by introducing a recovery period in the exposure experiments with NIS inhibitors, mainly with perchlorate. Greer et al., 2002, showed that after a recovery period of 15 days the inhibitory effect of perchlorate was eliminated, almost completely, as the measurements of iodide uptake were indistinguishable from their respective baseline values. Similar results were produced in other studies after a longer recovery period of 30 days, in which the iodide uptake as well as the serum TH levels returned to their baseline values (Siglin et al., 2000). The essential effect of NIS inhibition (MIE) to thyroidal iodide uptake (KE-downstream: decreased thyroidal iodide uptake) was also shown with the use of cells that did not endogenously express the NIS transfer protein (Cianchetta et al., 2010). In those experiments iodide was not transferred through the cellular membrane unless the cells were previously transfected with hNIS. Moreover, extensive studies on NIS protein have identified 14 different mutations and each one of them is related to Iodine Transport Deficiencies (ITD) (reviewed in Spitzweg and Morris, 2010).  Several other studies have proven that NIS inhibitors lead to a decrease of thyroidal iodide uptake resulting in a reduction of TH synthesis (KE-downstream) (Jones et al., 1996; Tonacchera et al., 2004; De Groef et al., 2006; Waltz et al., 2010).

 

Essentiality for the association between decreased TH synthesis (KE-upstream) and decreased thyroxin (T4) in serum (KE-downstream) is proven also by studies showing the effects of NIS inhibitors on TH homeostasis and synthesis (Dong et al., 2017; Calil-Silveira et al., 2016; Tang et al., 2013; Liu et al., 2012; Pearce et al., 2012). For instance, compounds, such as triclosan, triclocarban, 2,2',4,4'-tetrabromodiphenyl ether (BDE-47), and bisphenol A (BPA) have been reported to disturb TH homeostasis by inducing an inhibition of NIS-mediated iodide uptake and decreasing the expression of genes involved in TH synthesis, as shown in rat thyroid follicular FRTL-5 cells, and on the activity of TPO, using rat thyroid microsomes (Wu Y et al., 2016).

Perchlorate, thiocyanate, nitrate, and iodide, competitive inhibitors of iodide uptake, have been shown to inhibit radioactive iodide uptake by NIS (Tonacchera et al. 2004). Consequentially, these compounds also inhibit TH synthesis. In particular, perchlorate blocks iodide uptake into the thyroid gland and decreases the production of TH (Steinmaus, 2016a, 2016b).

 

Essentiality data for proving direct link  between decreased thyroxin (T4) in serum (KE-upstream) and decreased thyroxine (T4) levels in neuronal tissue (KE-downstream), are derived from mutation studies of the monocarboxylate transporter 8 (MCT8), a specific transporter for the T4 and T3 that allows their entry in the brain and other organs. MCT8 in the CNS is expressed in the cerebral cortex, hippocampus, and amygdala, as well as in hypothalamic neuroendocrine nuclei, in tanycytes, in choroid plexus structures, and in capillary endothelial cells of the blood-brain barrier, as highlighted by studies in mouse and human brain tissues (Mayerl et al., 2014). Mutations in MCT8 (Allan-Herndon-Dudley syndrome, AHDS) are characterised by normal to high TSH, elevated plasma T3, low T4, and decreased TH signaling in discrete brain areas (Kersseboom et al., 2013). Subjects affected by AHDS show a severe form of X-linked truncal hypotonia, spasticity, and mental retardation (McAninch and Bianco, 2014; Anık et al., 2014; López-Espíndola et al., 2014). Moreover, mice characterized by single MCT8 deficiency showed low serum T4, elevated serum TSH and T3, and decreased T3-dependent gene expression in both the hypothalamus and the cortex (Stohn et al., 2016). Analogously, another study reported that MCT8 knock-out mice were characterized by high serum T3, low serum T4, and decreased forebrain TH content (Müller et al., 2014).

 

Essentiality data for proving direct association between decreased T4 in neuronal tissue (KE-upstream) and reduced release of BDNF (KE-downstream) come from in vivo studies on hypothyroid rat models, exposed to TPO inhibitors (MMI, PTU), and/or NIS inhibitor (perchlorate). Offspring showed reductions in BDNF mRNA and protein levels, and the most affected brain regions were two brain structures critical for learning and memory processes, such as hippocampus and cortex, and the cerebellum (Koibuchi et al., 1999; 2001; Sinha et al., 2009; Neveu and Arenas, 1996)

 

Essentiality data for proving direct association between decreased release of BDNF (KE-upstream) and altered GABAergic interneurons morphology and function (KE-downstream), and indirect association between decreased release of BDNF (KE-upstream) and decreased synaptogenesis (KE-downstream) come from several in vivo studies in rats, showing that prenatal exposure to TPO inhibitors (PTU or MMI, to induce hypothyroidism),  decreased components of the GABAergic system (e.g., number of glutamic acid decarboxylase 65 (GAD65)+ and number of parvalbumin (PV)+ cells) (Sawano et al., 2013; Shiraki et al., 2012; Gilbert et al., 2007).

Moreover, a study showed that blocking BDNF with antibodies greatly reduced the formation of GABAergic inhibitory synapses (Seil and Drake-Baumann, 2000), while Yamada and colleagues found that treatment with BDNF elicited a significant increase of GABAA receptor in cultured hippocampus-derived neurons (Yamada et al., 2003). Westerholz et al., (2013), by using rat T3-deficient cultures of cortical PV+ interneurons, found that the number of synaptic boutons was reduced, and exogenous BDNF application abolished this effect. Also, inhibition of BDNF by K252a (a TrK antagonist) in cultures containing T3 resulted in decreased number of synaptic boutons, as in the T3-deprived cultures (Westerholz et al., 2013).

Chen and colleagues showed that GABAergic innervations of pyramidal neurons of BDNFMet/Met mice (characterized by a reduced activity-dependent BDNF secretion and elevated anxiety-like behaviours) are reduced at distal dendrites in hippocampal CA1 and medial prefrontal cortex, compared to wild type mice (Chen et al., 2016).

Furthermore, tyrosine receptor kinase B (TrkB, BDNF receptor) mutant mice showed reduced amounts of GABAergic markers and develop reduced numbers of GABAergic boutons and synaptic specializations (Rico et al., 2002).

In addition, Sato's study on rat cultured hippocampal slices showed that beta-estradiol (E2) induced synaptogenesis between mossy fibers (one of the major inputs to cerebellum) and hippocampal CA3 neurons by enhancing BDNF release from dentate gyrus (DG) granule cells, by increasing the expression of PSD95, a postsynaptic marker. Importantly, E2 effects on in hippocampal slice cultures and subregional neuron cultures were completely inhibited by blocking the BDNF receptor (TrkB) with K252a or by using a function-blocking antibody to BDNF, which inhibited the expression of PSD95 induced by E2. Both K252a and the antibody anti-BDNF elicited a decrease of spine density and presynaptic sites (Sato et al., 2007).

Along the same line, Schjetnan and Escobar, (2012) assessed in adult rats the effects of an intrahippocampal microinfusion of BDNF, which modulated the ability of the hippocampal mossy fiber pathway to produce long-term potentiation (LTP) by high frequency stimulation.  On the opposite, administration of the TrkB inhibitor K252a, in combination with BDNF, blocked the functional and morphological effects produced by BDNF. These data confirm the role of BDNF in the regulation of synaptic plasticity.

Schildt et al., (2013) performed field potential recordings in CA3 of adult heterozygous BDNF knockout (BDNF+/-) mice, and found that a decrease of NMDAR-independent mossy fiber LTP occurred in these mice. Additionally, inhibition of TrkB/BDNF signaling with K252a, or with the selective BDNF scavenger TrkB-Fc (on brain slices) both inhibited mossy fiber LTP to the same extent as observed in BDNF+/- mice.

 

Essentiality data for proving direct association between altered GABAergic interneurons morphology and function (KE-upstream) and decreased synaptogenesis (KE-downstream) are derived from studies on potassium chloride co-transporter 2 (KCC2), which is expressed almost exclusively in CNS neurons (Payne et al., 1996) and plays a major role in neuronal Cl homeostasis by maintaining a low neuronal [Cl]i. KCC2 expression is finely regulated during brain development, and KCC2 is thought to be the regulator of GABA switch (from excitatory to inhibitory) during early neuronal development (Lee et al., 2005; Chudotvorova et al., 2005). Transcriptional repression of KCC2 in rat cortical neurons was found to delay the GABA switch, corresponding to significant changes of [Cl]i in GABAergic neurons (Yeo et al., 2009). Importantly, the absence of T3 in cultures of cortical GABAergic interneurons can delay the typical developmental KCC2 up-regulation and subsequently the GABA shift, with a profound decrease in the number of synapses (Westerholz et al., 2010; 2013).

A further confirmation of KCC2 role comes from a study from Yeo and coworkers (2013), who found that bisphenol-A (BPA), a toxicant known to inhibit NIS-mediated iodide uptake (Wu Y et al., 2016) decreased KCC2 mRNA expression and attenuated [Cl]i shift in migrating cortical inhibitory precursor neurons, as observed in primary rat cortical neurons and primary human cortical neurons (Yeo et al., 2013).

 

Essentiality data for proving direct association between decreased synaptogenesis  (KE-upstram) and decreased neuronal network function in developing brain (KE-downstream) come from studies on developmental hypothyroidism, which has been found to be associated with decreased synaptic function, particularly in the hippocampus. Structural deficits can underlie functional deficits revealed in synaptic transmission and plasticity impairments (Vara et al., 2002, Sui and Gilbert, 2003, Gilbert, 2004, Dong et al., 2005, Sui et al., 2005; Gilbert and Paczkowski, 2003, Gilbert and Sui, 2006, Gilbert, 2011, Gilbert et al., 2013). Importantly, pyramidal neurons of hypothyroid animals have fewer synapses and an impoverished dendritic arbor (Rami et al., 1986, Madeira et al., 1992). Moreover, knockdown of the postsynaptic marker PSD95 arrests the functional and morphological development of glutamatergic synapses (Ehrlich et al., 2007).

 

Essentiality data for proving a direct association between decreased neuronal network function in developing brain (KE-upstream) and learning and memory deficits (AO) is strongly supported by several studies showing that alterations in synaptic transmission and plasticity contribute to deficits in cognitive function. A number of studies have linked exposure to TPO inhibitors (e.g., PTU, MMI), as well as iodine deficient diets, to changes in serum TH levels, which result in alterations in both synaptic function and cognitive behaviors (Akaike et al., 1991; Vara et al., 2002; Gilbert and Sui, 2006; Axelstad et al., 2008; Taylor et al., 2008; Gilbert, 2011; Gilbert et al., 2016).

Some hippocampal regions (i.e., area CA1 and dentate gyrus) exhibit alterations in excitatory and inhibitory synaptic transmission following reductions in serum TH in the pre and early postnatal period (Vara et al., 2002; Sui and Gilbert, 2003; Sui et al., 2005; Gilbert and Sui, 2006; Taylor et al., 2008; Gilbert, 2011; Gilbert et al., 2016). These deficits persist into adulthood, long after recovery to euthyroid status.

Some epidemiological and in vivo studies have indicated associations between a lower iodide uptake (e.g., as a consequence of an exposure to perchlorate) and decreased cognition. For instance, Taylor and coworkers found that levels of urinary perchlorate (a NIS inhibitor) assessed in a cohort study of 21,846 women, were positively associated with a higher risk for having children with lower IQ scores at 3 years of age (Taylor et al., 2014).

van Wijk's study assessed the behavioural effects of perinatal and chronic hypothyroidism during development in offspring of hypothyroid rat dams (both dams and offspring were exposed to sodium perchlorate (NIS inhibitor) via drinking water). The Morris water maze test, used to assess cognitive performance, showed that chronic hypothyroidism negatively affected spatial memory (van Wijk et al., 2008).

Weight of Evidence Summary

Biological Plausibility: The functional relationship between NIS and thyroidal iodide uptake is well established. In the human, NIS mutations are associated with congenital iodide transport defect, a condition characterized by low iodide uptake, hypothyroidism and goiter (Bizhanova and Kopp, 2009; De La Vieja et al., 2000; Pohlenz and Refetoff, 1999). The same is true for the relationship between iodide uptake and serum TH concentration, as it is known that Iodide Deficient (ID) suffer also by low thyroid levels in the blood (Wolff, 1998; DeLange, 2000). The correlation of serum and brain concentrations of TH are supported by a smaller amount of quantitative data but the biological plausibility of this connection is mainly based on the number of studies that show that the brain TH is proportional to the serum TH (Broedel et al., 2003). BDNF is thought to underlie the effects of developmental hypothyroidism but this notion is based mainly on their common physiological role during brain development rather than on solid experimental evidence (Gilbert and Lasley, 2013). On the other hand, the role of BDNF on the GABAergic interneurons development and function is well established, as many experimental data have been produced the last decades in support to this relationship (Woo and Lu, 2006; Palizvan et al., 2004; Patz et al., 2004). It is also widely accepted that the GABAergic signalling and therefore the proper function of GABAergic interneurons is fundamental for the normal synapse formation, which in turn controls the neuronal network formation, maturation and function. Numerous studies have shown that the depolarizing GABA signalling is controlled by the intracellular Cl- concentration in the postsynaptic cells and is the first drive for synapse formation (Wang and Kriegstein, 2008; Cancedda et al., 2007; Ge et al., 2006; Chudotvorova et al., 2005; Akerman and Cline, 2006). This early synaptogenesis period is critical for the establishment of the basic neuronal circuitry, despite the fact that synaptogenesis is a continuous process throughout life (Rodier, 1995).

Dose-response concordance: Multiple events were considered together in only limited number of studies. There is overwhelming evidence that supports the concordance of NIS inhibition with the decrease of thyroidal iodide uptake or the lower levels of serum TH but these two events have rarely been tested together. However, in the few cases that the levels of thyroidal iodide and the serum TH levels are measured in the same study the results are mostly conflicting, mainly due to the well-developed compensatory mechanisms that exist to maintain the TH levels in the body. That means that the effects of NIS inhibitors might not be detectable in short-term or low-dose experiments. Perchlorate is a well-described NIS inhibitor and the interpretation of related studies is straightforward because thyroid is considered the critical effect organ of perchlorate toxicity (National Research Council 2005); thus, any effects of perchlorate on the nervous system are necessarily interpreted to be subsequent to inhibition of iodide uptake by the thyroid gland and to a reduction in serum THs. Indeed, the use of potassium or sodium perchlorate has contributed to the identification of a dose-response relationships between NIS inhibition and thyroidal iodide uptake (Greer et al., 2002; Tonacchera et al., 2004; Cianchetta et al., 2010; Waltz et al., 2010; Lecat-Guillet et al., 2007; 2008) but the respective concordance with serum TH was not shown in most of these studies. On the other hand, in the human and animal studies that revealed a strong dose-dependent association between perchlorate exposure and circulating levels of TH (Blount et al., 2006; Cao et al., 2010; Suh et al., 2013; Steinmaus et al., 2007; Steinmaus et al., 2013; Siglin et al., 2000; Caldwell et al., 1995; Argus research laboratories 2001; York et al., 2003; York et al., 2004), the decrease of thyroidal iodide was not investigated. The downstream effects of TH insufficiency are better understood and documented but the majority of the dose-response data are derived from hypothyroid rodents after exposure with propylthiouracil (PTU) and methimazole (MMI), which is the most common used chemicals for the production of hypothyroid state to animals. Those types of experiments give information on the mechanisms through which TH insufficiency leads to neurodevelopmental deficits, but this pathway cannot be connected with NIS inhibition as data on specific NIS inhibitors is still lacking. In regards to the downstream events in the pathway, there is a strong correlation between each KE but the majority of the studies have been performed under severe hypothyroid conditions (high doses of PTU and/or MMI, thyroidectomies); therefore it is difficult to establish the dose-response relationships in each one of them. The association between serum TH levels and BDNF protein in the brain is very well documented but with the exception of few cases (Chakraborty et al., 2012; Blanco et al., 2013) no dose-response experiments are available. The same problem is also encountered in the relationship between BDNF levels and the GABAergic function, as there is only one recent study (Westerholz et al., 2013) that describes a correlation between these two events, but the results are described on the basis of T3 presence or complete absence in the cultures, which does not allow the establishment of dose-response evaluation. However, a dose-response relationship has been shown in earlier studies between the T3 hormone and the density of synapses in cortical cultures, an effect which was paralleled with the electrical activity of the network (Westerholz et al., 2010; Hosoda et al., 2003). More recently, a model of low level TH disruption has been developed, in which different concentrations of PTU have been tested and the subsequent dose-response relationships with GABAergic interneurons expression, synaptogenesis and learning and memory deficits were established (Sui and Gilbert, 2003; Gilbert and Sui, 2006; Gilbert, 2011; Gilbert et al, 2006; Berbel et al., 1996). Additionally, results from animal studies with perchlorate have also shown a dose-dependent reduction in excitatory and inhibitory synaptic function leading to learning and memory impairments (Gilbert and Sui, 2008). In contrast, there is only limited data in support to the correlation between TH insufficiency and the neuronal network function, and no dose-response relationship can be established.

Temporal concordance: In regards to temporality, the concordance between the KEs from the NIS inhibition until the TH levels in the brain is well-established. It is widely accepted that the most important role of iodine is the formation of the thyroid hormones (T4 and T3) and that iodine deficiency early in development can cause severe hypothyroidism leading to irreversible neurocognitive impairments (DeLange, 2000; Zimmermann et al., 2006). The majority of the data on TH insufficiency is derived from studies performed in different developmental stages and this study design facilitates the establishment of temporal concordance between the downstream KEs in the AOP. In general, TH insufficiency during the prenatal and early post-natal period is correlated with deficits in GABAergic morphology and function, especially of PV-positive interneurons (Berbel et al., 1996; Gilbert et al., 2007; Westerholz et al., 2010; 2013), with the decrease of active synapses and of synchronized electrical activity in cortical networks (Westerholz et al., 2010; Hosoda et al., 2003). This developmental window is known to be critical for the brain development and therefore TH deficits during this period has been correlated with mental retardation and other neurological impairments in children, which in some cases are irreversible (Mirabella et al., 2000; Porterfield and Hendrich, 1993). In at least two studies multiple KEs have been considered together and provide important information on the temporality of the AOP. Westerholz et al., 2010 and 2013 have shown that TH insufficiency during the first two postnatal weeks may cause alterations in the morphology and function of PV-positive GABAergic interneurons, with subsequent effects on the number of active synapses and the electrical activity of the neuronal network. During the same period the inhibition of BDNF function was shown to be also involved in the formation of synaptic connections (Westerholz et al., 2013). Further investigation of the mediating mechanisms revealed that a critical function in the above mentioned cascade was the timely shift of GABA signalling from depolarization to hyperpolarization, a milestone in brain development. The GABA switch takes place at the end of the second postnatal week in rodents, and thus we can conclude that all the KEs are performed during the perinatal period up to 14 days postnatal, which fits in the overall AOP, as this is the critical period for synaptogenesis and subsequently for the proper development of learning and memory functions.

Quantitative Consideration

Some semi-quantitative data are available for the described KERs; however, further experimental work is needed to define thresholds suitable to assess when a given KE-downstream will be triggered by the KE-upstream.

References


Akaike M, Kato, N., Ohno, H., Kobayashi, T. (1991). Hyperactivity and spatial maze learning impairment of adult rats with temporary neonatal hypothyroidism. Neurotoxicol Teratol 13:317-322.

Akerman CJ, Cline HT. (2006). Depolarizing GABAergic conductances regulate the balance of excitation to inhibition in the developing retinotectal circuit in vivo. J Neurosci 26: 5117–5130.

Anık A, Kersseboom S, Demir K, Catlı G, Yiş U, Böber E, van Mullem A, van Herebeek RE, Hız S, Abacı A, Visser TJ. (2014). Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations. Horm Res Paediatr. 82(4):261-71.

Argus Research Laboratories. (2001). Hormone, thyroid and neurohistological effects of oral (drinking water) exposure to ammonium perchlorate in pregnant and lactating rats and in fetuses and nursing pups exposed to ammonium perchlorate during gestation or via material milk. Argus Research Laboratories, Inc. (as cited in U.S. EPA, 2002). Horsham,PA.

Axelstad M, Hansen PR, Boberg J, Bonnichsen M, Nellemann C, Lund SP, Hougaard KS, U H. (2008). Developmental neurotoxicity of Propylthiouracil (PTU) in rats: relationship between transient hypothyroxinemia during development and long-lasting behavioural and functional changes. Toxicol Appl Pharmacol 232:1-13.

Berbel P, Marco P, Cerezo JR, DeFelipe J. (1996). Distribution of parvalbumin immunoreactivity in the neocortex of hypothyroid adult rats. Neurosci Lett. 204(1-2):65-68.

Bizhanova A, Kopp P. (2009). The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinol 150:1084-1090.

Blanco J, Mulero M, Heredia L, Pujol A, Domingo JL, Sanchez Dc. (2013). Perinatal exposure to BDE-99 causes learning disorders and decreases serum thyroid hormone levels and BDNF gene expression in hippocampus in rat offspring. Toxicol 308:122-128.

Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL. (2006). Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ. Health Perspect. 114: 1865–1871.

Broedel O, Eravci M, Fuxius S, Smolarz T, Jeitner A, Grau H, Stoltenburg-Didinger G, Plueckhan H, Meinhold H, Baumgartner A. (2003). Effects of hyper- and hypothyroidism on thyroid hormone concentrations in regions of the rat brain. Am J Physiol Endocrinol Metab. 285: E470–E480.

Caldwell DJ, King JH, Kinkead ER, Wolfe RE, Narayanan L, Mattie DR. (1995). Results of a fourteen day oral-dosing toxicity study of ammonium perchlorate. Dayton, Ohio: Wright-Patterson Air Force Base, Tri-Service Toxicology Consortium, Armstrong Laboratory.

Calil-Silveira J, Serrano-Nascimento C, Laconca RC, Schmiedecke L, Salgueiro RB, Kondo AK, Nunes MT. (2016). Underlying Mechanisms of Pituitary-Thyroid Axis Function Disruption by Chronic Iodine Excess in Rats. Thyroid. Oct;26(10):1488-1498.

Cancedda L, Fiumelli H, Chen K, Poo MM. (2007). Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo. J Neurosci 27: 5224–5235.

Cao Y, Blount BC, Valentin-Blasini L, Bernbaum JC, Phillips TM, Rogan WJ. (2010). Goitrogenic anions, thyroid-stimulating hormone, and thyroid hormone in infants. Environ Health Perspect. 118:1332-1337.

Chakraborty G, Magagna-Poveda A, Parratt C, Umans JG, MacLusky NJ, Scharfman HE. (2012). Reduced hippocampal brain-derived neurotrophic factor (BDNF) in neonatal rats after prenatal exposure to propylthiouracil (PTU). Endocrinology 153:1311–1316.

Chen YW, Surgent O, Rana BS, Lee F, Aoki C. (2016). Variant BDNF-Val66Met Polymorphism is Associated with Layer-Specific Alterations in GABAergic Innervation of Pyramidal Neurons, Elevated Anxiety and Reduced Vulnerability of Adolescent Male Mice to Activity-Based Anorexia. Cereb Cortex. Aug 30.

Chudotvorova I, Ivanov A, Rama S, Hubner CA, Pellegrino C, Ben-Ari Y, Medina I (2005). Early expression of KCC2 in rat hippocampal cultures augments expression of functional GABA synapses. J Physiol 566: 671–679.

Cianchetta S, di Bernardo J, Romeo G, Rhoden KJ (2010). Perchlorate transport and inhibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L. Toxicol Appl Pharmacol. 243:372-380.

De Groef B, Decallonne BR, Van der Geyten S, Darras VM, Bouillon R. (2006). Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects. Europ J Endocr. 155:17-25.

De La Vieja A, Dohan O, Levy O, Carrasco N. (2000). Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol. Rev. 80: 1083–105.

Delange F. (2000). The role of iodine in brain development. Proc Nutr Soc 59(1):75-79.

Dong X, Dong J, Zhao Y, Guo J, Wang Z, Liu M, Zhang Y, Na X. (2017). Effects of Long-Term In Vivo Exposure to Di-2-Ethylhexylphthalate on Thyroid Hormones and the TSH/TSHR Signaling Pathways in Wistar Rats. Int J Environ Res Public Health. Jan 4;14(1). pii: E44.

Dong J, Yin H, Liu W, Wang P, Jiang Y, Chen J. (2005). Congenital iodine deficiency and hypothyroidism impair LTP and decrease C-fos and C-jun expression in rat hippocampus. Neurotoxicology 26:417-426.

Ehrlich I, Klein M, Rumpel S, Malinow R. (2007). PSD-95 is required for activity-driven synapse stabilization. Proc Natl Acad Sci U S A. 104: 4176-4181.

Ge S, Goh EL, Sailor KA, Kitabatake Y, Ming GL, Song H. (2006). GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 43: 589–593.

Gilbert ME. (2004). Alterations in synaptic transmission and plasticity in area CA1 of adult hippocampus following developmental hypothyroidism. Brain Res Dev Brain Res 148:11-18.

Gilbert ME. (2011). Impact of low-level thyroid hormone disruption induced by propylthiouracil on brain development and function. Toxicol Sci 124:432–445.

Gilbert ME, Hedge JM, Valentin-Blasini L, Blount BC, Kannan K, Tietge J, Zoeller RT, Crofton KM, Jarrett JM, Fisher JW. (2013). An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome. Toxicol Sci 132:177-195.

Gilbert ME, Lasley SM. (2013). Developmental thyroid hormone insufficiency and brain development: a role for brain-derived neurotrophic factor (BDNF)? Neurosci 239: 253-270.

Gilbert ME, Paczkowski C. (2003). Propylthiouracil (PTU)-induced hypothyroidism in the developing rat impairs synaptic transmission and plasticity in the dentate gyrus of the adult hippocampus. Brain Res Dev Brain Res 145:19-29.

Gilbert ME, Sanchez-Huerta K, Wood C. (2016). Mild Thyroid Hormone Insufficiency During Development Compromises Activity-Dependent Neuroplasticity in the Hippocampus of Adult Male Rats. Endocrinology 157:774-787.

Gilbert ME, Sui L. (2006). Dose-dependent reductions in spatial learning and synaptic function in the dentate gyrus of adult rats following developmental thyroid hormone insufficiency. Brain Res 1069:10–22.

Gilbert ME, Sui L. (2008). Developmental exposure to perchlorate alters synaptic transmission in hippocampus of the adult rat. Environ Health Perspect 116:752–760.

Gilbert ME, Sui L, Walker MJ, Anderson W, Thomas S, Smoller SN, Schon JP, Phani S, Goodman JH. (2007). Thyroid hormone insufficiency during brain development reduces parvalbumin immunoreactivity and inhibitory function in the hippocampus. Endocrinology 148:92–102.

Greer MA, Goodman G, Pleus RC, Greer SE. (2002). Health effects assessment for environmental perchlorate contamination: the dose response for inhibition of thyroidal radioiodine uptake in humans. Environm Health Persp. 110: 927-937.

Hosoda R, Nakayama K, Kato-Negishi M, Kawahara M, Muramoto K, Kuroda Y. (2003). Thyroid hormone enhances the formation of synapses between cultured neurons of rat cerebral cortex. Cell Mol Neurobiol 23:895-906.

Jones PA, Pendlington RU, Earl LK, Sharma RK, Barrat MD. (1996). In vitro investigations of the direct effects of complex anions on thyroidal iodide uptake: identification of novel inhibitors. Toxicol. In Vitro. 10: 149-160.

Kersseboom S, Kremers GJ, Friesema EC, Visser WE, Klootwijk W, Peeters RP, Visser TJ. (2013). Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution. Mol Endocrinol. May;27(5):801-13.

Koibuchi N, Yamaoka S, Chin WW. (2001). Effect of altered thyroid status on neurotrophin gene expression during postnatal development of the mouse cerebellum. Thyroid 11:205–210.

Koibuchi N, Fukuda H, Chin WW. (1999). Promoter-specific regulation of the brain-derived neurotrophic factor gene by thyroid hormone in the developing rat cerebellum. Endocrinol 140: 3955–3961.

Lecat-Guillet N, Merer G, Lopez R, Pourcher T, Rousseau B, Ambroise Y. (2007). A 96-well automated radioiodide uptake assay for sodium/iodide symporter inhibitors. Assay Drug Dev Technol 5:535-540.

Lecat-Guillet N, Merer G, Lopez R, Pourcher T, Rousseau B, Ambroise Y. (2008). Small-molecule inhibitors of sodium iodide symporter function. Chembiochem 9:889–895.

Lee H, Chen CX, Liu YJ, Aizenman E, Kandler K. (2005). KCC2 expression in immature rat cortical neurons is sufficient to switch the polarity of GABA responses. Eur J Neurosci. 21: 2593-2599.

Liu C, Wang C, Yan M, Quan C, Zhou J, Yang K. (2012). PCB153 disrupts thyroid hormone homeostasis by affecting its biosynthesis, biotransformation, feedback regulation, and metabolism. Horm Metab Res. Sep;44(9):662-9.

López-Espíndola D, Morales-Bastos C, Grijota-Martínez C, Liao XH, Lev D, Sugo E, Verge CF, Refetoff S, Bernal J, Guadaño-Ferraz A. (2014). Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination. J Clin Endocrinol Metab. Dec;99(12):E2799-804.

Madeira MD, Sousa N, Lima-Andrade MT, Calheiros F, Cadete-Leite A, Paula-Barbosa MM. (1992). Selective vulnerability of the hippocampal pyramidal neurons to hypothyroidism in male and female rats. J Comp Neurol 322:501-518.

Mayerl S, Müller J, Bauer R, Richert S, Kassmann CM, Darras VM, Buder K, Boelen A, Visser TJ, Heuer H. (2014). Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. J Clin Invest. May;124(5):1987-99.

McAninch EA, Bianco AC. (2014). Thyroid hormone signaling in energy homeostasis and energy metabolism. Ann N Y Acad Sci. Apr;1311:77-87.

Mirabella G, Feig D, Astzalos E, Perlman K, Rovet JF. (2000). The effect of abnormal intrauterine thyroid hormone economies on infant cognitive abilities. J Pediatr Endocrinol Metab. 13(2):191-4.

Müller J, Mayerl S, Visser TJ, Darras VM, Boelen A, Frappart L, Mariotta L, Verrey F, Heuer H. (2014). Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency. Endocrinology. Jan;155(1):315-25.

National Research Council (NRC). (2005). Health Implications of perchlorate ingestion. Washington, DC: National Academy Press.

Neveu I, Arenas E. (1996.) Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo. J Cell Biol 133:631–646.

Palizvan MR, Sohya K, Kohara K, Maruyama A, Yasuda H, Kimura F, et al. (2004). Brain-derived neurotrophic factor increases inhibitory synapses, revealed in solitary neurons cultured from rat visual cortex. Neurosci 126: 955–966.

Patz S, Grabert J, Gorba T, Wirth MJ, Wahle P. (2004). Parvalbumin expression in visual cortical interneurons depends on neuronal activity and TrkB ligands during an early period of postnatal development. Cereb Cortex 14:342–51.

Payne JA, Stevenson TJ, Donaldson LF. (1996). Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform. J Biol Chem. Jul 5; 271(27):16245-52.

Pearce EN, Alexiou M, Koukkou E, Braverman LE, He X, Ilias I, Alevizaki M, Markou KB. (2012). Perchlorate and thiocyanate exposure and thyroid function in first-trimester pregnant women from Greece. Clin Endocrinol (Oxf). Sep;77(3):471-4.

Pohlenz J, Refetoff S. (1999). Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism. Biochimie. 81(5):469-76.

Porterfield SP, Hendrich CE. (1993). The role of thyroid hormones in prenatal and neonatal neurological development--current perspectives. Endocr Rev. 14(1):94-106.

Rami A, Patel AJ, Rabie A. (1986). Thyroid hormone and development of the rat hippocampus: morphological alterations in granule and pyramidal cells. Neuroscience 19:1217-1226.

Rico B, Xu B, Reichardt LF. (2002). TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum. Nat Neurosci 5:225–233.

Rodier PM. (1995). Developing brain as a target of toxicity. Environ Health Perspect. 103 Suppl 6:73-76.

Sato K, Akaishi T, Matsuki N, Ohno Y, Nakazawa K. (2007). beta-Estradiol induces synaptogenesis in the hippocampus by enhancing brain-derived neurotrophic factor release from dentate gyrus granule cells. Brain Res. May 30;1150:108-20.

Sawano E, Takahashi M, Negishi T, Tashiro T. (2013). Thyroid hormone-dependent development of the GABAergic pre- and post-synaptic components in the rat hippocampus. Int J Dev Neurosci. Dec;31(8):751-61.

Schildt S, Endres T, Lessmann V, Edelmann E. (2013). Acute and chronic interference with BDNF/TrkB-signaling impair LTP selectively at mossy fiber synapses in the CA3 region of mouse hippocampus. Neuropharmacology. Aug;71:247-54.

Schjetnan AG, Escobar ML. (2012). In vivo BDNF modulation of hippocampal mossy fiber plasticity induced by high frequency stimulation. Hippocampus. Jan;22(1):1-8.

Seil FJ, Drake-Baumann R. (2000). TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis. J Neurosci 20: 5367–73.

Shiraki A, Akane H, Ohishi T, Wang L, Morita R, Suzuki K, Mitsumori K, Shibutani M. (2012). Similar distribution changes of GABAergic interneuron subpopulations in contrast to the different impact on neurogenesis between developmental and adult-stage hypothyroidism in the hippocampal dentate gyrus in rats. Arch Toxicol. Oct;86(10):1559-69.

Siglin JC, Mattie DR, Dodd DE, Hildebrandt PK, Baker WH. (2000). A 90-day drinking water toxicity study in rats of the environmental contaminant ammonium perchlorate. Toxicol. Sci. 57(1):61-74.

Sinha RA, Pathak A, Kumar A, Tiwari M, Shrivastava A, Godbole MM. (2009). Enhanced neuronal loss under perinatal hypothyroidism involves impaired neurotrophic signaling and increased proteolysis of p75(NTR). Mol Cell Neurosci 40:354–364.

Spitzweg C, Morris JC. (2010). Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol. 322: 56-63.

Steinmaus C, Miller MD, Howd R. (2007). Impact of smoking and thiocyanate on perchlorate and thyroid hormone associations in the 2001-2002 national health and nutrition examination survey. Environ Health Perspect.115:1333-8.

Steinmaus C, Miller MD, Cushing L, Blount BC, Smith AH. (2013). Combined effects of perchlorate, thiocyanate, and iodine on thyroid function in the National Health and Nutrition Examination Survey 2007-08. Environ Res. 123:17-24.

Steinmaus CM. (2016a). Perchlorate in Water Supplies: Sources, Exposures, and Health Effects. Curr Environ Health Rep. Jun;3(2):136-43.

Steinmaus C, Pearl M, Kharrazi M, Blount BC, Miller MD, Pearce EN, Valentin-Blasini L, DeLorenze G, Hoofnagle AN, Liaw J. (2016b). Thyroid Hormones and Moderate Exposure to Perchlorate during Pregnancy in Women in Southern California. Environ Health Perspect. Jun;124(6):861-7.

Stohn JP, Martinez ME, Matoin K, Morte B, Bernal J, Galton VA, St Germain D, Hernandez A. (2016). MCT8 Deficiency in Male Mice Mitigates the Phenotypic Abnormalities Associated With the Absence of a Functional Type 3 Deiodinase. Endocrinology. Aug;157(8):3266-77.

Suh M, Abraham L, Hixon JG, Proctor DM. (2013). The effects of perchlorate, nitrate and thiocyanate on free thyroxine for potentially sensitive subpopulations of the 2001-2002 and 2007-2008 National Health and Nutrition Examination Surveys. J Expo Sci Environ Epidemiol. (Epub ahead of print)

Sui L, Gilbert ME. (2003). Pre- and postnatal propylthiouracil-induced hypothyroidism impairs synaptic transmission and plasticity in area CA1 of the neonatal rat hippocampus. Endocrinology 144:4195–4203.

Sui L, Anderson WL, Gilbert ME. (2005). Impairment in short-term but enhanced long-term synaptic potentiation and ERK activation in adult hippocampal area CA1 following developmental thyroid hormone insufficiency. Toxicol Sci 85:647-656.

Tang JM, Li W, Xie YC, Guo HW, Cheng P, Chen HH, Zheng XQ, Jiang L, Cui D, Liu Y, Ding GX, Duan Y. (2013). Morphological and functional deterioration of the rat thyroid following chronic exposure to low-dose PCB118. Exp Toxicol Pathol. Nov;65(7-8):989-94.

Taylor PN, Okosieme OE, Murphy R, Hales C, Chiusano E, Maina A, Joomun M, Bestwick JP, Smyth P, Paradice R, Channon S, Braverman LE, Dayan CM, Lazarus JH, Pearce EN. (2014). Maternal perchlorate levels in women with borderline thyroid function during pregnancy and the cognitive development of their offspring: data from the Controlled Antenatal Thyroid Study.J Clin Endocrinol Metab. Nov; 99(11):4291-8.

Taylor MA, Swant J, Wagner JJ, Fisher JW, Ferguson DC. (2008). Lower thyroid compensatory reserve of rat pups after maternal hypothyroidism: correlation of thyroid, hepatic, and cerebrocortical biomarkers with hippocampal neurophysiology. Endocrinology 149:3521-3530.

Tonacchera M, Pinchera A, Dimida A, Ferrarini E, Agretti P, Vitti P, Santini F, Crump K, Gibbs J. (2004). Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid. 14: 1012-1019.

van Wijk N1, Rijntjes E, van de Heijning BJ. (2008). Perinatal and chronic hypothyroidism impair behavioural development in male and female rats. Exp Physiol. Nov;93(11):1199-209.

Vara H, Martinez B, Santos A, Colino A. (2002). Thyroid hormone regulates neurotransmitter release in neonatal rat hippocampus. Neuroscience 110:19-28.

Waltz F, Pillette L, Ambroise Y. (2010). A nonradioactive iodide uptake assay for sodium iodide symporter function. Anal Biochem. 396:91-95.

Wang DD, Kriegstein AR. (2008). GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J Neurosci 28: 5547–5558.

Westerholz S, deLima AD, Voigt T. (2010). Regulation of early spontaneous network activity and GABAergic neurons development by thyroid hormone. Neurosci 168:573–589.

Westerholz S, de Lima AD, Voigt T. (2013). Thyroid hormone-dependent development of early cortical networks: temporal specificity and the contribution of trkB and mTOR pathways. Front Cell Neurosci 7:121.

Wolff J. (1998). Perchlorate and the thyroid gland. Pharmacol Rev. 50: 89-105.

Woo NH, Lu B. (2006). Regulation of Cortical Interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist. 12: 43-56.

Wu Y, Beland FA1, Fang JL. (2016). Effect of triclosan, triclocarban, 2,2',4,4'-tetrabromodiphenyl ether, and bisphenol A on the iodide uptake, thyroid peroxidase activity, and expression of genes involved in thyroid hormone synthesis. Toxicol In Vitro. Apr;32:310-9.

Yamada MK, Nakanishi K, Ohba S, Nakamura T, Ikegaya Y, Nishiyama N, et al. (2002). Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J Neurosci 22:7580–5.

Yeo M, Berglund K, Augustine G, Liedtke W. (2009). Novel repression of Kcc2 transcription by REST-RE-1 controls developmental switch in neuronal chloride. J Neurosci 29:14652–14662.

Yeo M, Berglund K, Hanna M, Guo JU, Kittur J, Torres MD, Abramowitz J, Busciglio J, Gao Y, Birnbaumer L, Liedtke WB. (2013). Bisphenol A delays the perinatal chloride shift in cortical neurons by epigenetic effects on the Kcc2 promoter. Proc Natl Acad Sci U S A. 110(11):4315-20.

York RG, Funk KA, Girard MF, Mattie D, Strawson JE. (2003). Oral (drinking water) developmental toxicity study of ammonium perchlorate in Sprague-Dawley rats. Int J Toxicol. 22(6):453-64.

York RG, Barnett J Jr, Brown WR, Garman RH, Mattie DR, Dodd D. (2004). A rat neurodevelopmental evaluation of offspring, including evaluation of adult and neonatal thyroid, from mothers treated with ammonium perchlorate in drinking water. Int J Toxicol. 23(3):191-214.

Zimmermann MB, Connolly K, Bozo M, Bridson J, Rohner F, Grimci L. (2006). Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: a randomized, controlled, double-blind study. Am J Clin Nutr. 83:108-114.